Podcasts about Smaller

This week on the podcast, Zach Kazan welcomes Zach Weiss and Liam O'Donnell to the podcast to discuss a topic we've been thinking about privately for a while and have heard grumblings about elsewhere. Today we're asking a big question: is the watch industry out of ideas? We've all felt it in one way or another. There's a sense among certain enthusiasts that brands are repeating themselves, churning out conservative products that are proven sellers at the expense of innovating. But is that an insidery point of view? Maybe “innovation” isn't exactly what this centuries old industry is really about? We chat about how some brands play it safe, constantly trying to recapture the past (and why that's appealing to a lot of us) and how others are a little more daring, and how that impacts the entire industry. To stay on top of all new episodes, you can subscribe to The Worn & Wound Podcast on all major platforms including Apple Podcasts, Stitcher, Spotify, and more. You can also find our RSS feed here.And if you like what you hear, then don't forget to leave us a review.If there's a question you want us to answer you can hit us up at info@wornandwound.com, and we'll put your question in the queue. Show Notes Selten and Collector Community Watch Ho and Co. Team Up for a New Collaboration in Tahitian Mother of PearlFears Brings Mother of Pearl to the Brunswick, But Not In the Way You Might Expect@misterenthusiast on InstagramReview: Lorier Neptune CollectionA Vintage Collector's Perspective on the Longines Legend Diver ReissueThe Longines Legend Diver is Now Available in a Smaller, 39mm CaseBaselworld 2019: My Hands-On Opinion of the New Tudor Black Bay P01Urwerk Introduces the UR-10 SpaceMeterArken Introduces their Second Act with the Dual-Time Equipped Alterum[VIDEO] Grand Seiko Redefines Accuracy – Again: Introducing the 9RB2 U.F.A. Spring Drive Caliber

This week on The Audit Podcast, our guest is Clarissa Lucas, author of Beyond Agile Auditing. Back by popular demand, Clarissa discusses whether auditing with agility is more of a mindset or a methodology—and why focusing on the why matters more than the how. She shares practical ways teams can move from a "practice-first" approach to an agile mindset and highlights key agile practices supported by recent research she's translated for the audit community.   Be sure to connect with Clarissa on LinkedIn.   Also, be sure to follow us on our social media accounts on LinkedIn, Instagram, and TikTok.   Also be sure to sign up for The Audit Podcast newsletter and to check the full video interview on The Audit Podcast YouTube channel.   Timecodes:   2:15 – Clarissa's Favorite AI Prompt 10:46 – Auditing With Agility 14:18 – Shifting the Mindset Around Agile Methodology 17:04 – Anchoring to the "Why" 19:02 – Why a "Practices-First" Approach Doesn't Work 21:50 – How to Effectively Measure the "Why" 27:43 – The Importance of Feedback Loops 31:17 – Breaking Work into Smaller, Manageable Batches 32:09 – Helpful Resources for Auditors 36:10 – Use Case Corner: Managing Too Many Stand-Ups 41:10 – Final Thoughts   *   This podcast is brought to you by Greenskies Analytics, the services firm that helps auditors leap-frog up the analytics maturity model. Their approach for launching audit analytics programs with a series of proven quick-win analytics will guarantee the results worthy of the analytics hype.  Whether your audit team needs a data strategy, methodology, governance, literacy, or anything else related to audit and analytics, schedule time with Greenskies Analytics.

Our software helps ecommerce brands build workflows that get them found in LLMsSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Stop calling it strategy. Most leaders are not doing strategy; they are managing a glorified to-do list. In this episode of Reflect Forward, I sit down with Simon Severino, author of Strategy Sprints, TEDx speaker, Forbes contributor, and CEO of Strategy Sprints, to talk about how to lead with clarity, focus, and speed. Simon helps leaders design an operating rhythm that turns lofty visions into measurable weekly wins, all without adding more meetings or complexity. Simon has spent over two decades helping leaders enter markets, scale effectively, and remain competitive in uncertain times. His Strategy Sprints method replaces long planning cycles with focused 90-day sprints that keep teams learning, adapting, and moving fast. It is a system designed for real-life scenarios, where uncertainty is constant and leaders cannot afford to wait for perfect information. Simon reminds us that strategy is not about being right; it is about learning fast. His Focus Card is a simple but powerful tool: one page for your strategy, one tab for weekly metrics. Every Monday, teams set their priorities. Every Friday, they review what is working and what is not. It is a rhythm that keeps everyone focused and aligned, turning strategy from theory into practice. Simon also challenges leaders to build like Lego, not Duplo, modular, flexible, and fast to reconfigure. When markets shift, teams that move in small, adaptable units thrive. That mindset is not just tactical, it is cultural. It encourages curiosity, experimentation, and speed. The beauty of Simon's method is its simplicity. It does not add complexity; it removes it. The Strategy Sprint approach helps leaders focus on what matters, cut through noise, and lead teams that win through clarity and cadence. My Takeaways 1. Plans list tasks. Strategy makes bets. Great leaders take responsibility for the assumptions they make. 2. Measure both cause and effect. Track the activities and the results they create. 3. Shorten your feedback loop. A Monday and Friday rhythm beats quarterly reviews every time. 4. Build modular. Smaller, faster systems are easier to adapt when the market shifts. 5. Seek truth, not validation. Try to invalidate your assumptions weekly. If they hold up, you are truly winning. When I asked Simon what he wished leaders understood about strategy, he said: “Do not try to prove you are right. Try to prove yourself wrong. If your assumptions survive, then you are winning.” And if you want to bring more focus and agility to your team, try Simon's Focus Card exercise. You might be surprised at how much clarity one page can bring. Connect with Simon https://www.linkedin.com/in/simonseverino/ https://www.facebook.com/simon.severino https://x.com/simonseverino https://www.strategysprints.com/ Connect with Kerry Visit my website, kerrysiggins.com, to explore my book, The Ownership Mindset, and get more leadership resources. Let's connect on LinkedIn, Instagram, or TikTok! Find Reflect Forward on YouTube: https://www.youtube.com/@kerrysiggins-reflectforward Find out more about my book here: https://kerrysiggins.com/the-ownership-mindset/ Connect with me on LinkedIn: https://www.linkedin.com/in/kerry-siggins/

View this video at https://macmost.com/how-to-export-smaller-pdfs-from-pages.html. When you create a Pages document with images and export to a PDF file, you often get a much larger PDF than expected. Here is why this happens and how to do things the right way to make smaller PDFs.

You know that burst of excitement when you start something new — and then life happens? The energy fades, motivation slips, and suddenly your big goal starts gathering dust. If that sounds familiar, you are not alone.  In today's episode, I'm sharing how to push past procrastination and finally finish what you start. Whether it's a work project, a fitness goal, or a personal passion you keep putting off, these strategies will help you reignite your focus, cross that finish line. When you leave things unfinished, it chips away at your self-belief. But when you complete what you set out to do, you're sending a message to your brain that says, “I follow through. I get things done.” Try these 3 Strategies today!1. Reconnect With Your “Why” When procrastination shows up, it's usually because your purpose got blurry. I want you to pause and remind yourself why you started. Ask, “What made this important to me?” When you reconnect with your why, you'll reignite your drive and focus. 2. Shrink the Task, Not the Dream Big goals can feel overwhelming — that's when most people stall out. Instead of trying to tackle everything at once, I want you to shrink it down. Focus on the next 15 minutes, not the next 15 steps. Smaller wins create momentum, and once that momentum builds, procrastination doesn't stand a chance. 3. Create Accountability That Works Let's be honest — it's easy to break promises to ourselves, but harder to let someone else down. Tell a friend, colleague, or coach what you're committing to this week. That one extra layer of accountability can make the difference between “I'll do it someday” and “I did it.” Until next time, this is Dr. Dawn reminding you: you've got everything it takes — now it's time to see it through. NEW HERE? Check out our Mentioned Videos: ·       The Career Woman's Secret Playbook Podcast: https://www.youtube.com/watch?v=6fR_clXjZ-4&list=PLdguFjdYMwqWXnvIeSAIhDrtPdHdsLGde ·       Mindset & Confidence Secrets: https://www.youtube.com/watch?v=klxaMDeQCXU&list=PLdguFjdYMwqXrgiI1YaB87uHu1gm_mczc ·       Upskilling Secrets: https://www.youtube.com/watch?v=Bm6ro9LlUMA&list=PLdguFjdYMwqX3gnuMSrLgaN7hXBSWhqmO ·       Building your Brand Secrets: https://www.youtube.com/watch?v=PRK7Ep29SkQ&list=PLdguFjdYMwqVLPsFZjl-Do8eH7leltW8O Get your copy of The Career Woman's Secret Playbook! ·       Amazon: https://www.amazon.com/Career-Womans-Secret-Playbook Contact Me! ·        https://www.drdawnshoptalk.com/book-online Grab your Freebies! https://www.drdawnshoptalk.com/career-secrets https://www.youtube.com/@drdawnshoptalk/podcasts

Across the globe, there is a shift in the size of families as birthrates decline. Communities, schools, and workforces are all shrinking at an alarming rate. Even in the wealthiest countries populations are aging and straining key social systems. How are smaller families changing the world and what does it mean for our future? Explore the full series at npr.org/populationshift.Learn more about sponsor message choices: podcastchoices.com/adchoicesNPR Privacy Policy

Today - Wenatchee schools are bracing for a steep enrollment drop in the years ahead — and officials say it could reshape the district for the next decade.Support the show: https://www.wenatcheeworld.com/site/forms/subscription_services/See omnystudio.com/listener for privacy information.

Have you thought about investing into space? Mark Boggett, CEO of Seraphim, shares the investment opportunities in the rapidly expanding space industry. He explains how innovations led by SpaceX dramatically lowered launch costs and increased access to space, catalyzing growth in satellite constellations and data-driven applications for defense, climate, and communications. He emphasizes that near-term investment potential lies in defense and climate-related uses of satellite data, rather than speculative ventures like space travel or asteroid mining. He also highlights the growing importance of sustainability, debris management, and more. We discuss... Mark Boggett is a career technology investor who founded Seraphim Space, the world's first space-focused investment fund. Seraphim Space operates a global accelerator, a private venture fund, and a publicly listed growth fund on the London Stock Exchange. Boggett shifted focus to space investing after recognizing how technologies like AI, telecommunications, and 3D printing were transforming the sector. SpaceX revolutionized space access by reducing launch costs from $86,000 to $1,000 per kilogram and dramatically increasing launch frequency. Smaller, cheaper satellites now enable massive constellations that provide real-time Earth observation and global connectivity. Investment opportunities in space fall into three categories: upstream (launch and satellites), downstream (data and applications), and in-space (future lunar and interplanetary activities). The most investable areas today are defense and climate-related satellite data applications rather than speculative space travel or mining. The falling cost of launch is paving the way for large-scale space infrastructure, including future data centers powered by solar energy. Space debris is an emerging challenge, driving new industries focused on monitoring, avoiding, and removing defunct satellites. Regulatory changes now require satellite operators to deorbit defunct satellites within five years, accelerating growth in orbital cleanup services. Defense is a major driver of demand for satellite technology in intelligence, communications, navigation, and asset protection. The "in-space" category includes lunar landers, space stations, and eventual habitation or mining ventures, though these remain long-term prospects. NASA's new funding model relies on private companies like Axiom Space and Voyager to build commercial space stations. Boggett concludes that while long-term prospects like lunar mining are exciting, the current trillion-dollar opportunity lies in satellites, data, and communication serving Earth-based customers. Today's Panelists: Kirk Chisholm | Innovative Wealth Phil Weiss | Apprise Wealth Management Douglas Heagren | Mergent College Advisors Follow on Facebook: https://www.facebook.com/moneytreepodcast Follow LinkedIn: https://www.linkedin.com/showcase/money-tree-investing-podcast Follow on Twitter/X: https://x.com/MTIPodcast For more information, visit the show notes at https://moneytreepodcast.com/investing-into-space-mark-boggett-760

My guests on the show are Michael Demaray and Vishal Mishra of Bard Associates, a boutique wealth management firm that has been in business since the 1980s. Michael and Vishal are true value investors who like to look in places other investors neglect. Specifically, Bard invests in a space that is near and dear to my heart: US microcap stocks. In this informative conversation, we discussed: The strategies that Bard runs today for its clients; The firm's long history of investing in small companies; Why some microcap stock prices are so volatile; The common characteristics of a core Bard holding; and The firm's approach to interacting with company management. Please see Bard's website for more information: https://www.bardassociatesinc.com/

Elona Ymeri is the service delivery manager at Assist Digital. She is based in Tirana, Albania. Elona spoke to Mark Hillary about the role of smaller BPO destinations. What can they offer that is harder to find from the big locations? Is the continued influence of AI and other automation technology reducing the need to consider working in locations where large numbers of agents can be found? Elona talked about Albania within this context, but also explored beyond Albania alone to consider other locations in Europe that might have an interesting and innovative new approach to BPO. https://www.linkedin.com/in/elonaymeri/ https://assistdigital.com/ ---- Summary: Mark Hillary and Peter Ryan introduce an interview with Elona Ymeri, the service delivery leader at Assist Digital in Tirana, Albania. Alona highlights Albania's mature BPO sector, employing nearly 30,000 people, and its strategic position as a nearshore option for European companies. She emphasizes Albania's cultural alignment, linguistic skills, and the country's investment in AI and digital transformation. Alona also discusses the shift towards intelligent operations, combining human talent with technology, and the importance of compliance and strategic partnerships in the future of BPO.

For a group that normally seems to nail ideas and present them well, the New Zealand Initiative this week went off-piste with their "MMP After 30 Years" report. Smaller cabinet - good idea. Get rid of the overhang - good idea! But more MP's? What on Earth are they thinking? The main point they make is that it has provided a fairer, more representative Parliament and I think, even for those of us that didn't vote for MMP, we pretty much would all need to conceed that. The question I would have is, is that what we actually want? The base level argument over representation is, do some of the lesser lights represent a sector of lesser lights in the wider community? If the community has got its collection of halfwits and buffoons, do we want a slice of that in the nation's Parliament because that is a version of representation? I would argue no. I would argue that I'd far rather have a selection of highly qualified, dedicated, hard-working professionals. But if a cross section is what we voted for, then a cross section is what we have received. The great fraud of MMP has been the oft-used line by people like the Green's Rod Donald that the tail would not wag the dog. The tail has most certainly wagged the dog, many times over. If the circumstances are right, and they have been more than once, a very small percentage of the vote can wield an astonishing and destructive amount of power. Then of course if we are marking 30 years, we can also relitigate the issue of knowledge at the time. MMP won not because it was better, or the best, but because MMP had the best run anti-FPP campaign and too many New Zealanders couldn't be bothered educating themselves about the alternatives. So MMP had the biggest headlines and enough people were fed up with Muldoon and Lange and scraps and bulldozing Governments so they threw out the current, in the hope the new was better. We will not change the system again. Those days are gone and I doubt we will ever even tinker with it. But if we do, more MP's will not be top of our wishlist. LISTEN ABOVESee omnystudio.com/listener for privacy information.

In today's episode, Clark has an update on the housing market, and how “involuntary landlords” are benefitting tenants. Also, you may notice some changes to some restaurant menus that are good for both your wallet and your health. Housing Update: Segment 1 Ask Clark: Segment 2 Smaller Portions: Win-Win: Segment 3 Ask Clark: Segment 4 Mentioned on the show: Submit a complaint | Consumer Financial Protection Bureau Checking monthly statements key defense against credit card hacks Net Worth Calculator - Clark.com The next big thing on menus: Smaller portions When Do You Tell a Car Dealership You're Paying Cash? Where Should You Keep Your Cash Reserve? Money Market Funds: What They Are, How They Work 18 of the Best High-Yield Online Savings Accounts in October 2025 How To Get Your Financial Affairs In Order  Clark.com resources: Episode transcripts Community.Clark.com  /  Ask Clark Clark.com daily money newsletter Consumer Action Center Free Helpline: 636-492-5275 Learn more about your ad choices: megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

My guest on the show today is Doug Porter, Portfolio Manager and Senior Research Analysts at Acuitas Investments. Doug and his team recently published a new white paper titled, "The Case for MicroCap." For most of you listening in, you're already a diehard MicroCap-per, and we've all succumbed to the altar to the merits of hunting in inefficient markets. Having said that, I invited Doug on here to not only remind us why we are here, why we hunt for the best investment ideas in our neck of the woods, but more importantly, in my opinion, to showcase why in 2025, the case for investing in MicroCaps has merit as a place to build wealth and allocate capital. Doug breaks down the structural inefficiencies and long-term opportunity in the micro-cap equity market — a segment that remains largely ignored by big institutions, but continues to be fertile ground for alpha generation. We discuss why micro-caps have historically outperformed in 84% of rolling 30-year periods, the critical role of active management in filtering out the riskiest names, and why Doug believes we're in the early innings of a new cycle that favors smaller companies. Doug also explains how “Stable Operators” — profitable, cash-generating niche businesses — are among the most compelling yet overlooked opportunities in today's market, and why a dedicated micro-cap allocation can offer diversification, M&A upside, and even a liquid alternative to private equity. Finally, we cover Acuitas's approach to identifying skilled micro-cap managers across the globe — and how this ecosystem of small, research-driven funds continues to uncover value where few others are looking. For more information about Doug Porter and Acuitas Investments, please visit: https://acuitasinvestments.com/ Planet MicroCap Podcast is on YouTube! All archived episodes and each new episode will be posted on the Planet MicroCap YouTube channel. I've provided the link in the description if you'd like to subscribe. You'll also get the chance to watch all our Video Interviews with management teams, educational panels from the conference, as well as expert commentary from some familiar guests on the podcast. Subscribe here: http://bit.ly/1Q5Yfym Click here to rate and review the Planet MicroCap Podcast The Planet MicroCap Podcast is brought to you by SNN Incorporated, The Official MicroCap News Source, and the Planet MicroCap Review Magazine, the leading magazine in the MicroCap market. You can Follow the Planet MicroCap Podcast on Twitter @BobbyKKraft

Chelsea Ryckis is the award-winning founder and president of Ethos Benefits, a firm dedicated to advancing fiduciary-driven health insurance strategies for employers nationwide to eliminate fraud, waste, and abuse from employer healthcare plans while increasing savings for both employers and their employees. After suffering a traumatic brain injury as a Division 1 college athlete, Canadian-born Chelsea experienced the US healthcare system firsthand, inspiring her pioneering entrepreneurship in healthcare. Chelsea was awarded the industry's most prestigious award, Advisor of the Year, by Benefits Pro in 2024. She has also been named the Most Innovative Healthcare Consultant in the United States for 2024. Chelsea is the co-host of the Ethos Effect Podcast with her husband Donovan and producer of the documentary "It's Not Personal, It's Just Healthcare."

You have heard of creatine, but you have no idea how much your body actually relies on it. Amy Hudson and Dr. James Fisher explore what creatine really is, why it matters for your health and performance, who should be using it, and how it actually works. They also tackle what the science actually says, how to use it in a way that makes sense for your lifestyle, and why so many people from athletes to everyday health seekers consider it a game changer. Expect to walk away with practical takeaways you can use immediately, whether your goal is to train harder, improve recovery, support brain health, or simply live with more energy. Dr. Fisher starts by explaining what creatine is and what it does. It is one of the most researched supplements in the world and plays a direct role in how your body produces energy. Think of it as fuel storage that your muscles, brain, and organs can tap into when they need a boost. Why is creatine so important? According to Dr. Fisher, creatine is essentially your body's backup battery for energy, powering everything from your muscles to your brain. Without it, you would not be able to perform at your best physically or mentally. Dr. Fisher explains how creatine boosts performance and allows you to exercise harder and longer. Why athletes swear by creatine. From Olympic sprinters to football players, it is one of the most widely used supplements in sports. If you want to train like the best, creatine has likely been part of their routine. Dr. Fisher highlights creatine health benefits that go beyond the gym. Studies show creatine can lower cholesterol, protect your liver, and even help with blood sugar control. It is also linked to reducing bone loss, supporting brain health, and minimizing the risk of serious diseases. Amy and Dr. Fisher cover why vegetarians may benefit even more from creatine. Since plant based diets do not provide as much creatine naturally, supplements can make an even bigger difference. And yes, vegan friendly options are widely available. According to Dr. Fisher, creatine is not just for athletes anymore. It is now considered a supplement for overall health and healthy aging. Amy and Dr. Fisher cover the types of creatine. You can buy it as a pill, a powder, or even gummies. But the gold standard, the one most research supports, is creatine monohydrate. Dr. Fisher on dosage: how much should you take daily? Research shows three to five grams per day is enough for most people. Smaller individuals may only need two to three grams, while larger athletes might go slightly above five. Does creatine cause water retention? Dr. Fisher says no, there is no research to back that up. That old loading phase of 20 grams a day was more marketing than science, so stick to the steady daily dose. Is creatine an anabolic steroid? Absolutely not. It has nothing to do with steroids chemically or functionally, so you can safely separate the two in your mind. Is creatine safe for children and teens? While there is less research in younger groups, studies show no evidence of harm. Still, Dr. Fisher emphasizes focusing first on diet, sleep, hydration, and exercise before adding supplements. Does creatine increase fat mass? Amy and Dr. Fisher reveal how creatine helps build lean muscle, which actually helps reduce body fat. If anything, it works in your favor for body composition. Dr. Fisher busts the myth that creatine is only for strength athletes. It is not just for bodybuilders or powerlifters, it has broad health benefits for anyone. That is why today, it is considered more of a wellness supplement than a performance only one. Is creatine only effective for men? According to Dr. Fisher, women benefit just as much. In fact, creatine may even support hormonal health, mood, and energy across the menstrual cycle. Mentioned in This Episode: The Exercise Coach - Get 2 Free Sessions! Submit your questions at StrengthChangesEverything.com This podcast and blog are provided to you for entertainment and informational purposes only. By accessing either, you agree that neither constitute medical advice nor should they be substituted for professional medical advice or care. Use of this podcast or blog to treat any medical condition is strictly prohibited. Consult your physician for any medical condition you may be having. In no event will any podcast or blog hosts, guests, or contributors, Exercise Coach USA, LLC, Gymbot LLC, any subsidiaries or affiliates of same, or any of their respective directors, officers, employees, or agents, be responsible for any injury, loss, or damage to you or others due to any podcast or blog content.

TWS News 1: Favorite Songs to Give Birth To – 00:26 Smaller or Taller Game – 3:06 Monday School: “What If” Loop – 8:29 TWS News 2: Non-Essential Backpay – 13:36 Are You Kidding Me Weekend – 16:57 TWS News 3: CFA Vending Machine – 20:07 Impressed By an Old Person – 22:56 Rock Report: No to Cosmetic Procedures – 27:27 Biblical Baddies – 30:13 I Can Only Imagine 2 Trailer – 35:39 30K Support Drive Challenge – 39:20 You can join our Wally Show Poddies Facebook group at www.facebook.com/groups/WallyShowPoddies

One of the biggest questions subscription box owners ask is: Where do I find products for my box? There's no single “right” answer because the best sourcing strategy depends on where you are in your business journey.  In this quick Friday Fuel episode of The Launch Your Box Podcast, I'm breaking down three key sourcing methods - wholesale, trade shows, and manufacturing - and showing you how each one fits a different stage of subscription box growth. Stage 1: Just Getting Started. Start with Wholesale If you're still prepping for launch or working toward your first 50–100 subscribers, wholesale is your best friend. It's flexible, affordable, and helps you learn what your audience loves without over-committing. Why it works: Low minimums let you order small quantities. Fast turnaround means you can ship quickly. It's the easiest way to test different product types. Challenges with wholesale: Smaller profit margins. Less exclusivity. Limited branding options Stage 2: You've Launched. Trade Shows & Curated Finds Once you've launched and built momentum, it's time to elevate your box. Trade shows and curated wholesale marketplaces help you discover unique, small-batch, and boutique items that give your box that “wow” factor. Why it works: You'll find more distinctive products. Meeting vendors face-to-face often leads to better pricing or exclusivity. You can start building your signature brand style. Challenges with trade shows and curated marketplaces: Travel costs and larger order requirements. Longer lead times mean planning boxes further ahead. Stage 3: Ready to Scale. Manufacturing When your subscription is stable and you're ready to increase margins or stand out even more, manufacturing can be a game-changer. But there are two levels to consider: Option 1: Stock Product from Manufacturers Buy from manufacturer catalogs and add your own branding or packaging. This is a great bridge between wholesale and full custom. Pros: better margins, faster turnaround, and the ability to add your own brand touches. Cons: limited product selection and minimal exclusivity. Option 2: Full Custom Manufacturing Design your own products from scratch for total control and differentiation. Pros: complete customization, higher perceived value, stronger brand identity. Cons: higher minimums, longer timelines, and bigger upfront costs. Sourcing Is a Journey, Not a Jump You'll probably use all of these sourcing methods at some point: Start with wholesale. Grow into trade shows. Add manufacturer stock for better margins. Move to custom products when you're ready. Take Action Identify your current sourcing stage and make one move this week that aligns with it: New? Order your first wholesale products. Growing? Research an upcoming trade show or apply for a wholesale marketplace account. Scaling? Reach out to a manufacturer and ask about their minimums. Every step forward brings you closer to the box and the brand you're meant to build. Join me for this episode, where I'll help you figure out which sourcing strategy fits your stage of business and how to take the next step with confidence. Join me in all the places:     Facebook Instagram Launch Your Box with Sarah Website Are you ready for Launch Your Box? Our complete training program walks you step by step through how to start, launch, and grow your subscription box business. Join the waitlist today!

What does true diversification look like when you're building wealth as a pilot? In this episode, Ryan Gibson sits down with his longtime colleague and friend, Ted Greene, to unpack how to define success with your spouse, avoid emotional investing, and create a portfolio that brings peace of mind. From surviving Wall Street lawsuits to building lasting wealth through real estate, Ted shares the hard-earned lessons behind his “NNN Principle”: Never, Never, Never invest by looking in the rearview mirror. Learn how to protect your assets, ladder your investments, and build a plan that lasts through every market cycle.Ted Greene is the Investor Relations Manager for Spartan Investment Group. Ted is a third-generation Seattleite who married his high school sweetheart. Ted and Melissa have two children attending the same High School where they first met. After graduating from Seattle Pacific University with a BA in Finance, Ted spent 24 years in the financial services industry as an investment advisor and Fiduciary.Download Ted's Ebook here: https://go.spartan-investors.com/l/1038393/2025-09-17/39mf5bShow notes:(0:00) Intro(1:30) Ted's background: Merrill Lynch to Spartan(3:10) Defining success through diversification(5:22) Why Ted left Wall Street(6:44) How to align with your spouse on money(9:38) What “uncorrelated assets” really mean(12:00) The 50-question eBook on financial alignment(14:49) Concentration builds wealth, diversification protects it(19:20) The NNN Principle: Never, Never, Never(22:18) Smaller positions, smarter protection(25:22) Laddering investments for flexibilityConnect with Ted Greene:LinkedIn: https://www.linkedin.com/in/ted-greene-iamnotafraid/—If you're interested in participating, the latest institutional-quality self-storage portfolio is available for investment now at: https://turbinecap.investnext.com/portal/offerings/8449/houston-storage/ — You've found the number one resource for financial education for aviators! Please consider leaving a rating and sharing this podcast with your colleagues in the aviation community, as it can serve as a valuable resource for all those involved in the industry.Remember to subscribe for more insights at PassiveIncomePilots.com! https://passiveincomepilots.com/ Join our growing community on Facebook: https://www.facebook.com/groups/passivepilotsCheck us out on Instagram @PassiveIncomePilots: https://www.instagram.com/passiveincomepilots/Follow us on X @IncomePilots: https://twitter.com/IncomePilotsGet our updates on LinkedIn: https://www.linkedin.com/company/passive-income-pilots/Do you have questions or want to discuss this episode? Contact us at ask@passiveincomepilots.com See you on the next one!*Legal Disclaimer*The content of this podcast is provided solely for educational and informational purposes. The views and opinions expressed are those of the hosts, Tait Duryea and Ryan Gibson, and do not reflect those of any organization they are associated with, including Turbine Capital or Spartan Investment Group. The opinions of our guests are their own and should not be construed as financial advice. This podcast does not offer tax, legal, or investment advice. Listeners are advised to consult with their own legal or financial counsel and to conduct their own due diligence before making any financial decisions.

You may have heard of bands like Nirvana and Sound Garden already, but Steve wants to put you on to some other great Seattle rock bands from that era!

If you've been grinding in the gym — logging hours of cardio, sweating through group classes, or lifting light weights for endless reps — yet your body still isn't responding, this episode is for you. In today's episode, I'm breaking down why the "eat less, move more" and "burn as many calories as possible" approach stops working as you hit midlife, and what to do instead. You'll learn the training shifts every woman over 35 needs to protect hormones, support metabolism, and actually see results without burning out. We'll talk about: The common workout mistakes that keep women stuck in the cycle of fatigue and frustration Why traditional cardio and circuit classes often backfire in midlife The exact types of workouts that help you build strength, improve hormonal health, and age powerfully How to finally feel energized, resilient, and confident in your training again If you're ready to stop working harder and start working smarter with your body, you don't want to miss this one. Resources & Links:

Hosts Jim Connelly (@jimmyconnelly), Derek Schooley (@derekschooley), and Ed Trefzger (@EdTrefzger) look at sometimes controversial or overlooked topics in our midweek episode called Upon Further Review.College hockey is experiencing a massive facilities arms race, with programs investing heavily in new arenas. Recent projects range from Union's $55 million M&T Bank Center to Northeastern's planned $300-350 million replacement for Matthews Arena, with notable investments at St. Thomas ($175M), Western Michigan ($100M+), and numerous other schools. The hosts debate whether this spending remains the primary recruiting advantage or if NIL money, revenue sharing, and player development have become equally important.A major concern: nine-figure construction costs could make college hockey unsustainable and deter program expansion.A key tension emerges around maintaining atmosphere during upgrades. Smaller, intimate venues like Cornell's Lynah Rink preserve the electric home-ice advantage that massive buildings often lose when they're harder to fill. The hosts note successful examples like UConn's compact arena and Union's decision to stay smaller rather than expand, while acknowledging the challenge of balancing modernization with the historic charm that makes college hockey special.Find all of our podcasts at USCHO.com/podcasts

In this episode of the Fit Over 40 Reset Podcast, we dive into why GLP-1 microdosing is becoming the smarter, safer, and more sustainable approach for women over 40.You'll learn:Why smaller, steadier doses are easier on your body than one big aggressive doseHow microdosing supports energy, focus, and long-term metabolic balanceThe surprising benefits for mood, muscle preservation, and hormonal healthIf you've been curious about medical weight loss but want something that works with your body — not against it — this episode is for you.

Summary? Can ants be farmers? Join Kiersten to find out!   For my hearing impaired followers, a complete transcript of this podcast follows the show notes on Podbean   Show Notes: “Tales from the Ant World” by Edward O. Wilson “Adventures Among Ants” by Mark W. Moffett Music written and performed by Katherine Camp   Transcript (Piano music plays) Kiersten - This is Ten Things I Like About…a ten minute, ten episode podcast about unknown or misunderstood wildlife. (Piano music stops)   Kiersten - Welcome to Ten Things I Like About… I'm Kiersten, your host, and this is a podcast about misunderstood or unknown creatures in nature. Some we'll find right out side our doors and some are continents away but all are fascinating.  This podcast will focus ten, ten minute episodes on different animals and their amazing characteristics. Please join me on this extraordinary journey, you won't regret it. Can ants be farmers? In this episode we are going to find out. The sixth thing I like about ants is their farming abilities. You may have heard of leafcutter ants. These are ants that cut leaves and carry them back to their colony. They are often highlighted in nature television programs. It's mesmerizing and charming watching a line of ants traveling with various sizes of leaf pieces held above their heads. Leafcutters will fall into one of two genera: Acromyrmex and Atta. There are 39 species that we currently know of and they are all found in the New World. Atta are most prevalent in the tropics of South America but there are two species that can be found in North America, one in Texas and Louisiana and one in Arizona.  Leafcutter ant nests can extend 7 meters, or 22 feet, into the earth and contain eight thousand chambers. The largest chamber is typically the ant waste chamber which is buried as far down as they can make it. The title of this episode is farmers so how does that relate to our leafcutter ants? Well, leafcutter ants are farmers. I used to think that they cut those little pieces of leaves to eat themselves, but that is not what they are doing. They take the leaves back to their nest where they feed it to fungus. They tend the fungus like farmers and then they eat the fungus, or rather the larvae eat the fungus. So I guess every leaf cutter ant eats the fungus at some point in their life.  The adult workers ants eat the sap from the leaf fragments that they cut. This is what energizes them to process the leaves. The leaves have to be mulched first before it is fed to the fungus. The fungus will grow and grow and grow in the leafcutter nest. It will fill up the majority of the chambers with a lightweight spongy structure that kind of looks like a human brain and is called a fungus garden. The ants tend the fungus by adding new leaves to the top and sides while they removed the older bottom portions.  It is unusual that ants are completely dependent on vegetation, but leafcutter ants are. The fungus is actually high in protein and that helps the larvae grow big and strong.   The largest nest that Mark Moffett ever came across during his studies was in the Kaw Mountains of French Guiana. The above ground soil mounds were chest high and ranged over a 14 meter wide area. It ranged over about 160 square meters in total. If we compared this to a human made structure, it would be bigger than the Empire State Building in New York City. This nest probably housed millions of workers.  A nest of this size can require an excavation of 40 tons of soil. It must house the queen, the brood, and the workers but even with millions of ants it's the fungus gardens that take up most of the real estate. The ant population can weigh up to 15 to 20 kilograms and utilize 280 kilograms of leaves. That's enough plant matter to blanket a soccer field. Now, this is a lot of living things inside an enclosed space, so it gets hot and humid. To combat increasing heat and humidity which slows down fungal growth, the ants have installed air conditioning ducts. The long tunnels that open above ground are placed strategically around the nest to release humidity and heat. If it get too cold, the tunnels will be closed off.  The only reason leafcutter ant nests can support millions of workers is because they are farmers. Just like humans, farming allows the ants to support a larger population by creating their own resources. These ants use incredibly advanced farming techniques. Humans will use various farming equipment to produce large quantities of crops, but for leafcutter ants its all hands on deck. The ants within this species are highly polymorphic, meaning sizes between workers vary greatly depending on your job. The largest soldier ant is 200 times bigger than that of a small worker. These colonies are run like assembly lines of self-directed individuals. Many steps are managed by ants in a variety of sizes. Mid-size workers cut the foliage, carry it into the nest, and deposit it onto the garden surface. Smaller ants with 1.6 millimeter wide heads take the next step which is shredding the greens into scraps.The next step is accomplished by even smaller ants who chew up the scraps into moist pulp. Still smaller ants will insert the pulp into the gardens. Then ants with 1 mm sized heads will lick the pulp and seed it with tufts of fungus from established fungal gardens. This is just like a human horticulturist using cuttings from a vine to establish a new crop! The smallest workers with a head width of 0.8mm remove contaminants from the gardens such as bacteria, yeast and spores.  Just like any good farmer, the ants use fertilizer to help their gardens grow. They don't have to go far to get the fertilizer, they just poop on the leaves. The ammonia and amino acids in the feces helps breakdown the leaves and encourages growth.  To retrieve the plant matter that grows the fungal gardens, leaf cutter ants will maintain almost permanent trails. Other species of ants trails vary depending on where they can find resources, but leafcutter ants are loyal to their grocery stores. Another caste of ants larger than the workers we have already discussed but smaller than soldiers that defend the nest are the maintenance crew for the paths. They will dismantle anything that gets in their way. They haul off debris that they can heft and chew through things they can't. They widen and smooth out the path until traffic is flowing again. They can do this quickly as they are present on the paths at all times! Boy, don't we all wish our highways were that well maintained! There is still one more layer to these superhighways. Worker ants that are smaller than the ladies hauling the leaf parts home will scamper about under the plant carriers and reinforce the pheromone trails. As we discussed before, these pheromone trail are super important for ant communication.  With all of these layers of responsibility, levels of workers, and intricate cooperation, some believe that leaf cutter ants are the gold standard of superorganisms. Quoting from Edward Wilson's book, Tales from the Ant World, “So well-marked and powerful is the division of labor among members of a leaf colony that individual colonies can be reasonably called a superorganism.” The definition of a superorganism is an organized society that functions as an organic whole. Leafcutter ants must have every layer of worker functioning correctly to survive, any deviation and the whole organism dies.  Edward Wilson goes on to say, “The leafcutters are superorganisms that succeed under natural conditions.” I think we have established that ants can be farmers and very successful farmers at that! Thanks for joining me for episode six because my sixth favorite thing about ants is their ability to farm.  If you're enjoying this podcast please recommend me to friends and family and take a moment to give me a rating on whatever platform your listening. It will help me reach more listeners and give the animals I talk about an even better chance at change.  Join me next week for another exciting episode about ants.        (Piano Music plays)  This has been an episode of Ten Things I like About with Kiersten and Company. Original music written and performed by Katherine Camp, my very own piano playing hero.

Plus: Chinese battery giant Contemporary Amperex Technology reports higher quarterly profit. And a former antitrust official predicts regulatory scrutiny of energy deals to power data centers. Zoe Kuhlkin hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices

I'm working with a client who is a gifted communicator with years of real-world experience. He kept hearing that paid speaking is off limits unless you are already well known, can sell tickets by name alone, or have a massive audience. I knew that wasn't the full story. So I brought in someone I trust and have known for nearly 15 years, Grant Baldwin, to walk through what actually works today for getting paid to speak without celebrity status. Grant has trained thousands of speakers and built The Speaker Lab into a respected, enduring brand, one that has ranked on the Inc. 5000 list of the fastest, growing privately held companies in the United States for five consecutive years. What This Episode Is… And Who It's For This conversation is designed for strong communicators who are comfortable on a stage and want to translate that skill into paid opportunities. If that's you, you'll find a clear framework, realistic fee guidance, what event planners actually want, and the specific outreach and follow-up cadence that moves you from “aspiring” to “booked.” Core Mindset Shift: From “Be Famous” To “Solve A Specific Problem” Event planners aren't always evaluating your follower count. They are reducing risk. They want a reliable speaker who can solve one specific problem for one specific audience and make the organizer look like a hero for choosing wisely. If Oprah or a former president is headlining, tickets sell on name alone. For the rest of us, the job is to solve a defined problem so well that attendees are grateful and organizers are relieved they chose us. The trap to avoid: “I can speak to anyone about anything.” Don't be a buffet. Be a steakhouse. A steakhouse does one thing exceptionally well. Most buffets do many things mediocre. Your positioning must signal sharp focus, not “I do it all.” Practical implication: Choose a niche problem and audience, and let everything else in your marketing reinforce that narrow, valuable focus. The SPEAK Framework Grant Teaches (And How To Apply It) Grant uses a five-part framework. I'll restate it with my commentary and application steps you can take immediately. S - Select a problem to solve Pick one clear problem for one identifiable audience. Validate it by confirming that organizations actually hire speakers on that topic. Avoid niche passions that no one budgets for on stage. Look for the Venn overlap between what you love, what you're skilled at, and what event buyers pay for. Quick validators you can run this week: Make a list of real conferences or associations where your topic would fit. Start with local, state, and regional events rather than national headliners that pay six figures to celebrity keynoters. Identify a few working speakers one or two steps ahead of you as benchmarks. If no one exists in your proposed niche, that's not a blue ocean. It's likely a market that doesn't buy talks on that topic. P - Prepare your talk Design a talk that offers a concrete solution to the chosen audience's felt need. Make sure the talk aligns with what planners already hire speakers to address. Your talk is a product. It must reduce the organizer's risk and fulfill the promise in the program description. Tip: If there's a personal subtopic you care about that isn't a main-stage draw, embed it as a 5 to 10 percent segment within a widely purchased theme, rather than making it the headline. This blends your passion with market reality without performing a bait-and-switch. E - Establish yourself as the expert You need a sharp, professional website and a demo video. Event planners who hire speakers will compare you to several other speakers. Your materials must look as good or better than your fee peers, because people judge books by their covers, especially under risk. You do not need to spend tens of thousands, but you do need clarity and quality. What to include: Crisp positioning: audience, problem, outcome. A talk page with titles, descriptions, and learning outcomes. Select testimonials that match your audience and topic. A short, high-quality demo reel showing stage presence and audience engagement. A - Acquire paid speaking gigs This is where most speakers falter. Do not wait passively for inquiries. Identify target events, start conversations, and follow up with discipline. Smaller events are not “lesser.” They are accessible and often pay in the $1,000 to $5,000 range for quality speakers who fit well. Those reps build momentum and referrals. A starter outreach line that works: “When will you start reviewing speakers for your [season/year] event?” You're aligning to their process, not forcing a pitch at the wrong time. If they say, “in three months,” get explicit permission to follow up, then actually follow up in three months with a helpful, short note. They won't expect you to do it. Showing up reliably previews how good you'll be to work with. My added tactic: Use Facebook groups where your audience gathers to crowdsource a list of live events they already attend. Ask, “If someone wanted to fully immerse in solving [problem], what live events should they attend?” Now you have a prospect list drawn from the market itself. Then apply the outreach process above. I share the exact post volume thresholds and how I used this approach during my Free The Dream years. K - Know when to scale Speaking can be the whole business or the front end of a larger business. Some speakers aim for many gigs and fee growth. Others use speaking primarily to acquire coaching, consulting, or long-term clients worth tens of thousands, which can dwarf the fee itself. Decide your model early, then shape your targeting and topic accordingly. What To Charge When You're Getting Started Set expectations realistically. Most speakers who are early in their professional journey charge between $1,000 and $5,000 for the first several paid gigs, with growth as reps, results, and marketing assets improve. Fees vary by industry: corporations generally pay more than nonprofits, for example. Your website, demo video, testimonials, and relevance to that organizer's audience all factor into perceived value. If you are already collecting checks in the $10,000 to $25,000 range, you're likely in a pond that routinely books at that level, with the credentials and references to match. Your materials and proof must stand shoulder to shoulder with other speakers priced similarly. The decision-maker is weighing risk. Your job is to make the yes feel safe. How Event Planners Think: Risk, Fit, Proof Event planners and committees are in the risk mitigation business. They need to justify why choosing you is safe. The fastest way to help them feel safe is to present tightly aligned positioning, a clear solution for their audience, relevant testimonials, and a professional demo that shows what they will see on their stage. If you're a known quantity in their industry, you reduce risk further. Translation: Your niche experience matters. Even if you want to speak beyond your current industry later, start where you already have credibility and connections. Build momentum there, then expand. Be The Steakhouse, Not The Buffet We swapped a memorable story about a dinner in Vegas that nails this point. A top steakhouse has a short menu. It's exceptional at one thing. Too many speakers showcase a menu of twenty topics across every domain. That spreads you thin and confuses buyers. You don't become referable as “the person who solves X.” Choose X. Then keep saying X. Building Momentum: Breakouts, Workshops, Local and Regional Stages Keynotes are the glory slot, but many buyers hire outstanding breakout or workshop speakers they've never heard of. Target smaller, local, or state-level events where budgets are sensible and competition is less fierce. Use these to gather testimonials and in-industry proof. The more you speak, the more you speak. People in the seats are often the next bookers. Referrals compound. Proactive Prospecting And Follow-Up: Exactly How To Do It Most speakers fail because they wait. Here's a workable cadence: Build a prospect list of the right-fit events. Send a short, no-pressure opener: “When will you start reviewing speakers?” Capture their answer and permission to follow up. Follow up exactly when promised with a crisp, helpful note. Keep the thread warm with brief check-ins aligned to their process, not your pitch calendar. This shows the organizer what it's like to work with you. Reliability beats bravado. My supplement to this: Source events by asking active Facebook groups where your audience congregates which conferences they actually attend. Then research and contact those events using the cadence above. Two Viable Business Models: Fee-First vs. Lead-Gen-First Fee-first speakers optimize for the check, the travel schedule, and fee growth over time. Lead-gen-first speakers optimize for speaking to rooms filled with ideal buyers, then convert into higher lifetime value offers such as retainers, advisory, or premium programs. In some niches, a single client is worth more than the speaking fee. Choose the model that matches your goals and build your targeting and talk to support it. Host Your Own Stage To Create Reps And Proof You don't have to wait for an invitation. Design a focused one-day workshop around your problem-audience fit, sell tickets, and put yourself on stage. This both validates your topic and produces assets, testimonials, and compelling footage for your reel. Tactical Tips, Stories, And Subtleties You Might Miss On First Listen Expectations prevent discouragement. Speaker fees range from a few hundred to hundreds of thousands. Unless your name sells tickets, start where the market is and grow. Manage expectations early so you stay persistent long enough to break through. Industry matters. Corporate, association, education, nonprofit, faith, and government markets all have different norms and ranges. Choose the pond that fits your topic, background, and goals. Marketing assets are not optional. At minimum, have a professional, focused site and a tight demo. Decision-makers compare several speakers side by side. Present like a pro. Momentum is real. The more stages you're on, the more invitations you'll receive. Some referrals hit years later. Plant seeds now. Harvest later. Start where you have leverage. If your career was in real estate, restaurants, law, healthcare, or tech, begin there. You speak the language, know the players, and reduce buyer risk. You can always evolve your niche after you build proof. Breakouts build keynotes. Deliver great breakout sessions that solve concrete problems. That creates case studies and word of mouth that lead to higher-fee keynote opportunities. Small and local is a feature, not a bug. Many high-quality regional events have budgets in the $1,000 to $5,000 range and want excellent speakers who fit. Those are perfect on-ramps. Be personable and reliable. The subtle signals you send in email cadence, brevity, and clarity matter as much as your sizzle reel. Planners notice. Use audience hubs to find events. Facebook groups with significant daily activity are a goldmine for discovering exactly which conferences your market actually attends. Ask the right question, harvest the list, then do surgical outreach. Speaking as impact. Opportunities come in all shapes and sizes. Grant shared doing a virtual session for inmates in a county jail, and he has also spoken to arenas of 10,000. There isn't one “correct” venue. There are aligned venues for your mission and model. If You're A Strong Communicator And Ready To Start, Do This In The Next 7 Days Define your niche: Write a one-sentence positioning statement: “I help [audience] solve [problem] so they can [outcome].” Keep it painfully specific. List 25 target events: Use Google, LinkedIn, and active Facebook groups your audience frequents. Ask what events they already attend and compile answers. Tidy your materials: Ensure your site and speaker page reflect your niche clearly, with outcomes and a clean bio. If you don't have a reel, assemble a short, honest highlight cut from any footage you have. Send five concise outreach emails: “When will you start reviewing speakers for [event]?” Track replies. Ask for permission to follow up at their timeline. Build a simple follow-up system: Calendar reminders or a basic CRM. Follow up exactly when promised with a short, service-oriented note. Reliability is your advantage. Book or create one rep: Pitch a breakout locally or host a focused micro-workshop yourself. Capture testimonials and footage. Momentum starts here. Resources Mentioned The Speaker Lab website The Speaker Lab podcast The Speaking Fee Calculator The Successful Speaker book by Grant Baldwin My Closing Thought If you're gifted on stage and willing to do the unglamorous prospecting and follow-up, there is a clear, repeatable path to getting booked and paid. You do not need to be famous. You do need to be focused, professional, and persistent. Choose your “steak,” serve it beautifully to the right diners, and keep showing up. The rooms you want will start asking for you by name. Ready to Turn Your Experience Into Income? If you're still here reading this, I have a feeling I know something about you. You're a communicator, a creator, someone with real experience, skill, and a genuine desire to serve others. You've been working hard to build your business, grow your audience, and create content that helps people. Yet even with all that effort, the profit still doesn't reflect the impact you're making. If that sounds familiar, it might be time for a different approach. Over the years, I've worked with countless creators, coaches, and entrepreneurs who started by doing what everyone said they should: creating content, building websites, and growing an audience. The problem? That's actually Step 8 in the process of building a profitable business. They skipped the first seven steps, the ones that make everything else work. That's why I created my Building an Online Business Program. It's the same proven 11-step framework I've used and taught to help others finally see consistent, sustainable income from the work they love. The program includes my complete course, recorded live in the Next Level Studio, and two private 90-minute one-on-one coaching sessions with me. Those sessions are where we take what you're learning and apply it directly to your goals, your challenges, and your business model. It's personalized guidance designed to bring focus, clarity, and predictable income to your business. If you've been creating content for years but still feel like you're spinning your wheels, this is your chance to change that. You'll get the clarity, structure, and strategy that can finally convert your experience into income, and build the freedom you set out to create in the first place. Click Here To Learn More And Enroll Today Let's journey together.

CPG products are notoriously hard to launch, fund, and get onto shelves. That's why the failure rate is so high. But what if right now is actually the best time to do it? The barrier to entry has never been lower, the consumer has never been easier to reach, and the path from idea to traction has never been more open.  You can test, sell, and scale from your laptop without begging for retail space or burning through millions in capital. You can start lean, iterate fast, and build credibility through storytelling and traction. You can prove demand before you even produce at scale. Smaller brands are punching above their weight right now, building more influence, more loyalty, and more momentum than the legacy players. The big brands are getting squeezed, while upstarts are thriving in those small, high-end niches that used to feel impossible to break into. So the question isn't can small brands win; it's who's going to take advantage of this moment before the big players catch on? How do you make the CPG shift work in your favor? And if I were starting today, what strategy would I use to actually get funded? In this episode, we dig into what's really happening in the consumer product space and why niche, premium, mission-driven brands are quietly eating the big guys' lunch. Topics Covered; Why this might secretly be the best time to launch a CPG brand How small, focused brands are outpacing legacy giants The smartest ways to test and build traction on a budget Why “profitable and niche” beats “big and fast” every time The story investors actually want to hear (and it's not about scale) The mindset shift that makes entrepreneurship feel less daunting Startups Are Eating Big Food's Lunch   About Your Host   Jayla Siciliano, Shark Tank entrepreneur turned real estate investor, excels in building brands, teams, and products. CEO of a bi-coastal luxury short-term rental company, she also hosts the Seed Money Podcast, where she's on a mission to help early-stage entrepreneurs turn their ideas into reality!    Connect: Website: https://seedmoneypodcast.com/ Instagram: https://www.instagram.com/jaylasiciliano/ Subscribe and watch on YouTube https://www.youtube.com/@seedmoneypodcast/    Please rate, follow, and review the podcast on https://podcasts.apple.com/us/podcast/seed-money/id1740815877 and https://open.spotify.com/show/0VkQECosb1spTFsUhu6uFY?si=5417351fb73a4ea1/! Hearing your comments and questions helps me come up with the best topics for the show!   The information in this podcast is educational and general in nature and does not take into consideration the listener's personal circumstances. Therefore, it is not intended to be a substitute for specific, individualized financial, legal, or tax advice.  

Adam Crowley and Dorin Dickerson react to the Toronto Blue Jays winning the ALCS and advancing to the World Series.

From hiring freezes to shifting workforce priorities, federal HR teams are under pressure. But technology may offer a path forward, especially for smaller offices trying to stay ahead. That's the view of Rick Hammell, founder and CEO of Globalli.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

I am excited to have Dr. Yvonne Karney with me for a two-part series focused on breast imaging options and the importance of informed consent. In Part 1 today, we discuss the limitations of current breast screening options and how to protect yourself if you choose to get mammograms or MRIs. We also introduce you to QT Imaging, which is the future of breast imaging. Benefits of early detection: It allows for procedures like lumpectomy instead of extensive surgery Early-stage cancers often require less chemotherapy or radiation Detecting cancer early generally improves the chance of recovery and survival Smaller interventions preserve appearance and more tissue  Early treatment can be quicker, simpler, and less traumatic  Yvonne Karney's Bio: Yvonne Karney is a medical doctor, traditionally trained in gynecology, and a former United States Air Force physician, who converted to integrative medicine when she realized she didn't have the right tools to help her patients achieve true health.  She is the founder of Vitality Renewal Functional Medicine in the Chicago suburbs, where her newest venture is to revolutionize breast imaging by offering an option that has the image quality of MRI WITHOUT radiation, IV contrast, or painful compression.  She's on a mission to give women options for breast imaging and educate them about the risks and benefits of the current breast cancer screening recommendations.  In this episode: How mammograms are pushed without real informed choice The value of early detection   How false positives tend to fuel fear and lead to extra procedures Risks that come with breast compression and radiation How overdiagnosis leads to overtreatment The problems associated with MRIs  How true 3D imaging could change the future of breast screening Links and Resources: Guest Social Media Links: Vitality Renewal Breast Imaging Yvonne Karney on YouTube Yvonne Karney on Instagram Vitality Renewal Functional Medicine  Relative Links for This Show: Try Halo (Salt) Therapy for respiratory and skin health. Call 319-363-0033 to schedule your session. https://yourlongevityblueprint.com/product/glutathione-60-ct/ https://yourlongevityblueprint.com/product/coq10-100-mg/ Follow Your Longevity Blueprint  On Instagram| Facebook| Twitter| YouTube | LinkedIn Get your copy of the Your Longevity Blueprint book and claim your bonuses here Find Dr. Stephanie Gray and Your Longevity Blueprint online   Follow Dr. Stephanie Gray  On Facebook| Instagram| Youtube | Twitter | LinkedIn Integrative Health and Hormone Clinic Podcast production by Team Podcast

Got some sh!t to say?Marko and Steve are tackling one of gay culture's longest-standing debates — literally. This week, it's all about penis size and the ever-fascinating world of size queens. Why are we so obsessed with measurements, and does it actually matter when the lights go out? The guys go deep (pun intended) asking the hard questions: length or girth? And is it really about the motion of the ocean — or just having a bigger boat? To wrap things up, they tackle the week's Listener Sh!tuation, offering their thoughts and guidance on a real life dilemma from the audience.-Articles:Garcôn | Unraveling the Truth about Penis SizeQueerty | Gay Guys Sing the Praises of Smaller & Average-Sized MenLGBT Hero | Goldicocks: the penis issueSupport the showSh!t | Leave us a voicemail with your relationship sh!tuation at (903) POD- SHIT. That's (903) 763-7448. You can also fill out a Listener Sh!tuation on our website, podrelationshit.com, or email us at relationshitquestions@gmail.com. Visit Us |www.podrelationshit.com for more Relationsh!t content and information about the podcast.Donate | Head over to patreon.com/podrelationshit and start donating today! Your donations will give you early access to the podcast, behind-the-scenes interviews with our weekly guests, and merchandise.Rate Us | Go to your favorite podcast directory and give Relationsh!t a 5-Star rating, and a fantastic review!Follow Us | Instagram and Facebook: @podrelationshit

Welcome to Two-Minute Tuesdays, where you'll hear a non-diet devotional to help you fight the regular pressures of diet culture by resting in God's grace and following His joy. If you want these sent to your inbox daily for only $10, you can sign up at joyfulhealth.co/devo. “I really enjoyed this episode”

Cages should be only worn by tops! Smaller isn't always better! Chastity is only chastity when you need to get out! All these hot takes and more as we discuss our favorite and least favorite parts about chastity. Happy first week of locktober!— Use code WATTS or go to kink3d.com/WATTS for free Nether Nudger in Black or Arctic White w/purchase of any Cobra or Viper kit. —- Watts Socials -Discord: https://discord.gg/bxqDQVcKH7Amps Linktree: https://linktr.ee/pupampKristofer Linktree: https://linktr.ee/mrkristoferSAFEWORD MERCH: http://www.safewordshop.comTWITCH: http://twitch.tv/wattsthesafewordWatts Your Safeword Podcast:Itunes: http://apple.co/2QkMDwkSpotify: http://spoti.fi/2QjPNjLBluesky:https://bsky.app/profile/pupamp.bsky.socialhttps://bsky.app/profile/wattsthesafeword.bsky.socialhttps://bsky.app/profile/mrkristofer.bsky.socialTwitters:http://twitter.com/WattsTheSafewrdhttp://twitter.com/PupAmpInstagrams:https://instagram.com/PupAmp/https://instagram.com/mrkristoferwestonhttps://instagram.com/wattsthesafewordFacebook: http://ow.ly/Z5nvMPatreon: https://www.patreon.com/WattsTheSafewordOpening by the magical Aethernaut https://aethernaut.bandcamp.comMusic by Joakim Karud http://youtube.com/joakimkarud

If you've been spinning your wheels creating products that barely sell, this post is your shortcut. Lisa spent 6 months making 9 different digital products and earned under $300. Then she used one AI prompt—what we call the Product Goldmine Prompt—and did $12,000 in 30 days. This post gives you the exact strategy so you can do it too. The Real Problem Most Creators Miss Most creators choose offers based on gut and passion. Winners pick offers based on buyer psychology—problems people are already paying to solve. That's what the Product Goldmine Prompt surfaces in minutes. Show Notes: MiloTree Free Plan Product Goldmine AI Prompt 6 Purchasing Triggers Test Join The Blogger Genius Newsletter Become a Blogger Genius Facebook Group Subscribe to the Blogger Genius Podcast: iTunes YouTube Spotify The 6 Purchasing Triggers Behind Every Best-Selling Offer After analyzing 1,000+ launches, every profitable product reliably hits at least one of these six triggers: Make money Save money Save time Move toward happiness Move away from pain Raise social status Here's the kicker: “Make money” and “Save money” offers can outperform by 400% because they solve expensive problems. That's why a $297 tax-savings guide can outsell cute $27 planners—same effort, different trigger, bigger profit. The Product Goldmine Prompt (How It Works) This AI prompt gets you a list of ready-to-buy product ideas in your niche—mapped to triggers, target customers, prices, and hooks—so you're choosing winners before you build. What you'll get when you run it: 20 product ideas in your niche The exact problem each solves Target customer Suggested price point ($27–$497) Which trigger(s) the offer hits (prioritizing Make/Save Money) Why buyers would pay now A one-sentence marketing hook The prompt intentionally avoids oversaturated spaces and focuses on daily frustrations and costly problems—so you're picking offers with real demand.

Send us a textThe biological roots of sleep are tied to mitochondrial metabolism.Episode Summary: Dr. Gero Miesenböck discusses the evolutionary and metabolic basis of sleep, exploring how mitochondrial energy production in neurons, particularly in fruit flies, drives the need for sleep to manage harmful byproducts like reactive oxygen species and lipid peroxides. They discuss how sleep-inducing neurons sense these byproducts, the role of mitochondrial dynamics, and the broader implications for why all animals, from jellyfish to humans, require sleep. The conversation also touches on how body size and metabolism influence sleep needs across species.About the guest: Gero Miesenböck, MD is a professor of physiology at the University of Oxford, renowned for his pioneering work in optogenetics and his research on the neurobiology of sleep using fruit flies and mice.Discussion Points:Sleep is universal across animals, even in jellyfish without centralized brains, suggesting a fundamental metabolic purpose tied to mitochondrial energy production.Mitochondria produce energy efficiently using oxygen but generate reactive oxygen species that can damage cells through lipid peroxidation, necessitating sleep to repair this damage.Sleep-inducing neurons in fruit flies contain sensors that track lipid peroxidation products, acting like a digital memory to signal when sleep is needed.Smaller animals with faster metabolisms, like mice, require more sleep and have shorter lifespans due to higher oxygen consumption and oxidative stress.Mitochondrial diseases in humans often cause intense tiredness, likely due to increased electron leaks in the mitochondrial energy production process.The evolutionary origin of sleep likely stems from the oxygen revolution 2.5 billion years ago, enabling complex life but requiring mechanisms like sleep to manage metabolic side effects.Caloric restriction reduces sleep need by lowering the production of harmful metabolic byproducts, supporting the link between metabolism and sleep.Reference paper:Study: Mitochondrial origins of the pressure to sleepRelated content:M&M 12: Organisms, Cities, Companies & the Science of Scale | Geoffrey West*Not medical advice.Support the showAffiliates: Seed Oil Scout: Find restaurants with seed oil-free options, scan food products to see what they're hiding, with this easy-to-use mobile app. KetoCitra—Ketone body BHB + electrolytes formulated for kidney health. Use code MIND20 for 20% off any subscription (cancel anytime) Lumen device to optimize your metabolism for weight loss or athletic performance. Code MIND for 10% off SiPhox Health—Affordable at-home blood testing. Key health markers, visualized & explained. Code TRIKOMES for a 20% discount. For all the ways you can support my efforts

What if the secret to feeling strong and confident in midlife isn't about starting over—but finally doing the small, sustainable things you've been avoiding?In this episode, host Laurie Reynoldson talks with Renee Bellinger, a certified nutrition and health mindset coach with a background in counseling psychology. Renee is on a mission to help high-achieving midlife women get out of the all-or-nothing trap and finally build the foundation their future selves can stand on—without crash diets, guilt, or burnout.They also take on one of the buzziest tools in the weight loss world right now: GLP-1 medications. Renee shares her hot take on why rapid weight loss without habit change can backfire—and what you should focus on instead.This episode is packed with truth bombs, permission slips, and simple mindset shifts that will get you thinking about your body, your health, and your habits in a totally different way.

As AI tools race into every corner of software development, a simple question keeps coming back to me. Will AI replace human testers, or will it force us to rethink what great testing looks like in the first place. In today's conversation, I talk with Santiago Komadina Geffroy, a Software Engineer at Jalasoft and an educator with Jala University, about what changes, what stays, and what teams should do next. Santiago shares how his day job and teaching intersect. He points to a gap he sees often. Engineers are experimenting with large language models without fully understanding how they work, which leads to overconfidence and avoidable rework. He argues for clearer interaction patterns between tools and people. Think less about magic prompts and more about protocols, context sharing, and agent to agent collaboration. That shift frees testers to do the thinking work that AI still struggles with, from exploratory testing and usability judgment to spotting the weird edge cases that only show up when real humans use real products. We also get into bias and ethics. AI is only as fair as the data it learns from, and that matters in healthcare, finance, and hiring where a mistake can carry life changing consequences. Santiago calls for stronger education around data quality, authorship, privacy, and environmental impact, not as a side note but as part of how engineers are trained. He believes governance helps teams move faster with fewer regrets when they take AI into production. Security sits in the mix too. Many AI tools need deep system access. If compromised, they can distort results or leak sensitive information. Santiago is candid about the limits of any single safeguard. He recommends a culture of shared responsibility where engineers understand when to call in security specialists and how to design workflows that keep humans in the loop for consequential decisions. We close with what Jalasoft has learned from building with AI inside a nearshore model in South America. More thinking time. Smaller, controllable scopes. Clear lines between routine automation and human judgment. The headline is simple. AI will change testing. Human testers will remain at the heart of quality.

The Museum of Modern Art, also known as the MoMA, in New York City, is one of the most worthwhile museums to visit while in the city. With 5+ floors and hundreds of thousands of pieces, including works by Jackson Pollock, Pablo Picasso, and Paul Cézanne, there is something for everyone at this world-class museum.Before you go, listen to this episode covering some of the most famous art, tour options, ticket prices, and must-know tips for your museum visit.

Citadel Securities has begun processing trades for small and mid-tier banks in a partnership aimed at providing them better pricing on fixed-income securities, according to President Jim Esposito. He speaks with Bloomberg's Francine Lacqua at the Citadel Future of Global Markets Conference in New York.See omnystudio.com/listener for privacy information.

realDGC.com

Barings' John Lippmann and CBRE Investment Management's Elisabeth Troni share strategies for navigating risk and unlocking value in core real estate investment portfolios. From alternatives to secondary markets, top funds are adapting to outperform in a shifting landscape.Key takeaways on evolving investor strategies: · Alternatives are reshaping core portfolios, with newer funds allocating heavily to data centers, seniors housing and single-family residential.· Operational expertise is a performance driver, particularly in shorter-lease-term asset types that require service-oriented models.· Smaller markets offer strategic upside, with investor focus shifting to high-growth, affordable areas like El Paso and West Palm Beach amid demographic and affordability trends.· Flexible fund structures allow managers to hold through market cycles and avoid forced sales in illiquid environments.· Benchmarking tools enhance insights into income vs. appreciation return potential and help investors measure returns.

realDGC.com

‘I was pulled out of my shell' The fourth industrial revolution is underway, pushing people to retreat into metaphorical caves. The City of Caves, Tigguo Cobauc, Nottingham, England. The fear and the lure of the dark. To help support this Podcast & get exclusive videos every week sign up to Neil Oliver on Patreon.comhttps://www.patreon.com/neiloliver Gold Bullion Partners - for more info about buying gold & silver go to this affiliate link,https://goldbullionpartners.co.uk/download-our-complimentary-guide-neil-oliver/ To Donate,go to Neil's Website:https://www.neiloliver.com Shop:https://neil-oliver.creator-spring.com YouTube Channel:https://www.youtube.com/@Neil-Oliver Rumble site – Neil Oliver Official:https://rumble.com/c/c-6293844 Instagram - NeilOliverLoveLetter:https://www.instagram.com/neiloliverloveletter Podcasts:Season 1: Neil Oliver's Love Letter To The British IslesSeason 2: Neil Oliver's Love Letter To The WorldAvailable on all the usual providershttps://podcasts.apple.com/gb/podcast/neil-olivers-love-letter-to-the-british-isles #NeilOliver #England #Nottingham #Cityofcaves #Tiguocobauc #fourthindustrialrevolutuion #caves #history #neiloliverGBNews #travel #culture #ancient #historyfact #explore Hosted on Acast. See acast.com/privacy for more information.

It's been twenty years since The Biggest Loser first aired. In the last episode, we reflected on what The Biggest Loser taught us about ourselves and how the show shaped the way we view weight loss, health, and body image. In this episode, we focus on the progress we've made since then: the shift toward strength training, body composition over the scale, and celebrating sustainable health instead of crash diets. We ask tough questions, share personal experiences, and rethink what health really looks like NOW in 2025. Have you changed with the times? This is a raw, timely conversation for anyone still untangling themselves from the “before and after” mindset. CVG Facebook Group: Stronger Together(00:00:22) Welcome to the podcast and spooky season(00:07:08) Fun spooky vibe questions (00:16:00)  Recap of the last episode.(00:19:34)  Why it's so hard to praise health without praising weight loss.(00:25:40)  Are we still shaking off extreme makeovers and fad diets obsessions?(00:29:20)  Slow and steady wins: shifting away from quick fixes toward sustainable results.(00:33:40)  The rise of strength training: why muscle changed the conversation.(00:35:10)  Taking back the narrative: from reality TV edits to social media.(00:44:24)  Smaller bodies still receive more praise than larger bodies.(00:49:30)  One thing we can take away from the Biggest Loser era.Want to leave the TTSL Podcast a voicemail? We love your questions and adore hearing from you. https://www.speakpipe.com/TheThickThighsSaveLivesPodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The CVG Nation app, for ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠iPhone⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The CVG Nation app, for Android⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Our ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fitness FB Group⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Thick Thighs Save Lives Workout Programs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Constantly Varied Gear's ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Workout Leggings⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

It's been twenty years since The Biggest Loser first aired. In the last episode, we reflected on what The Biggest Loser taught us about ourselves and how the show shaped the way we view weight loss, health, and body image. In this episode, we focus on the progress we've made since then: the shift toward strength training, body composition over the scale, and celebrating sustainable health instead of crash diets. We ask tough questions, share personal experiences, and rethink what health really looks like NOW in 2025. Have you changed with the times? This is a raw, timely conversation for anyone still untangling themselves from the “before and after” mindset. CVG Facebook Group: Stronger Together(00:00:22) Welcome to the podcast and spooky season(00:07:08) Fun spooky vibe questions (00:16:00)  Recap of the last episode.(00:19:34)  Why it's so hard to praise health without praising weight loss.(00:25:40)  Are we still shaking off extreme makeovers and fad diets obsessions?(00:29:20)  Slow and steady wins: shifting away from quick fixes toward sustainable results.(00:33:40)  The rise of strength training: why muscle changed the conversation.(00:35:10)  Taking back the narrative: from reality TV edits to social media.(00:44:24)  Smaller bodies still receive more praise than larger bodies.(00:49:30)  One thing we can take away from the Biggest Loser era.Want to leave the TTSL Podcast a voicemail? We love your questions and adore hearing from you. https://www.speakpipe.com/TheThickThighsSaveLivesPodcast⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The CVG Nation app, for ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠iPhone⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠The CVG Nation app, for Android⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Our ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Fitness FB Group⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Thick Thighs Save Lives Workout Programs⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Constantly Varied Gear's ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Workout Leggings⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

Episode summary Joe and Mary dive into how platform censorship and shifting algorithms have reshaped psychedelic media, why DoubleBlind moved to a “newsletter-first” model, and what that's revealed about true audience engagement. They reflect on the post-2024 MDMA decision headwinds, state-level policy moves (wins and losses), and how funding, politics, and culture continue to reconfigure the field. They also explore alternatives to alcohol, chronic pain research, reciprocity around iboga/ibogaine, and lessons from PS25 (MAPS' Psychedelic Science 2025). Highlights & themes From platforms to inboxes: Social and search suppression (IG/FB/Google) throttled harm-reduction journalism; DoubleBlind's pivot to email dramatically improved reach and engagement. Post-MDMA decision reality: Investment cooled; Mary frames it as painful but necessary growth—an ecosystem “airing out” rather than a catastrophic pop. Policy pulse: Mixed year—some state measures stalled (e.g., MA), others advanced (e.g., NM; ongoing Colorado process). Rescheduling cannabis may add complexity more than clarity. Censorship paradox: Suppressing education makes use less safe; independent outlets need community support to keep harm-reduction info visible. Chronic pain & long COVID: Emerging overlaps and training efforts (e.g., Psychedelics & Pain communities) point beyond a psychiatry-only frame. Alcohol alternatives: Low-dose or occasional psychedelic use can shift habits for some; Mary stresses individual context and support beyond any single substance. Reciprocity & iboga: Rising interest (including from right-leaning funders) must include Indigenous consultation and fair benefit-sharing; pace of capitalism vs. community care is an active tension. PS25 field notes: Smaller, more manageable vibe than 2023; fewer “gold-rush” expectations; in-person dialogue beats online flame wars. Notable mentions DoubleBlind: Newsletter-first publishing; nurturing new writers and reported stories. Psychedelics & Pain Association / Clusterbusters: Community-driven models informing care and research (cluster headache protocols history). Books & media: Body Autonomy (Synergetic Press anthology); Joanna Kempner's work on cluster headaches - Psychedelic Outlaws; Lucy Walker's forthcoming iboga film. Compounds to watch: LSD (under-studied relative to MDMA), 2C-B, 5-MeO-DMT (synthetic focus), and broader Shulgin-inspired families.   Mary Carreon: [00:00:00] Okay, I'm gonna send it to my dad because he wants to know. Here Joe Moore: we go. Yeah, send it over. So, hi everybody. We're live Joe here with Mary Anne, how you doing today? Mary Carreon: I'm great Joe. How are you? Joe Moore: Lovely. I actually never asked you how to pronounce your last name does say it right? Mary Carreon: Yes, you did. You said it perfectly Joe Moore: lovely. Joe Moore: Um, great. So it's been a bit, um, we are streaming on LinkedIn, YouTube, Twitch X and Kick, I guess. Yeah. Kick meta. Meta doesn't let me play anymore. Um, Mary Carreon: you're in forever. Timeout. I got it. I got it. Yeah. Joe Moore: Yeah. I think they found a post the other day from 2017. They didn't like, I'm like, oh cool. Like neat, you Mary Carreon: know, you know. Mary Carreon: Yeah. That happened to me recently, actually. Uh, I had a post taken down from 2018 about, uh, mushroom gummies and yeah, it was taken down and I have strikes on my account now. So Joe Moore: Do you get the thing where they ask you if you're okay? Mary Carreon: Yes, with, but like with my searches though, [00:01:00] like if I search something or, or someone's account that has, uh, like mushroom or psychedelic or LSD or something in it, they'll be like, mm-hmm are you okay? Mary Carreon: And then it recommends getting help. So Joe Moore: it's like, to be fair, I don't know if I'm okay, but Yeah, you're like, probably not. I don't really want your help. Meta. Yeah. Mary Carreon: You're like, I actually do need help, but not from you. Thanks. Yeah, Joe Moore: yeah, yeah. Mary Carreon: So not from the techno fascists. Joe Moore: Oh, good lord. Yeah. Uh, we'll go there. Joe Moore: I'm sure. Mary Carreon: I know. I just like really dove right there. Sorry. Yeah. All right, so let's, Joe Moore: um, before we go, let's give people like a bit of, you know, high kicks on, on who is Mary, where you working these days and what are you doing? Mary Carreon: Yeah, thank you. My name is Mary Carryon and I am forever and first and foremost a journalist. Mary Carreon: I have been covering, I say the plant legalization spaces for the past decade. It's, it's been nine and a half years. Uh, on January 3rd it will be [00:02:00] 10 years. And I got my start covering cannabis, uh, at OC Weekly. And from there went to High Times, and from there went to Mary Jane, worked for Snoop Dogg. And then, uh, I am now. Mary Carreon: Double blind. And I have become recently, as of this year, the editor in chief of Double Blind, and that's where I have been currently sinking my teeth into everything. So currently, you know, at this moment I'm an editor and I am basically also a curator. So, and, and somebody who is a, uh, I guess an observer of this space more than anything these days. Mary Carreon: Um, I'm not really reporting in the same way that I was. Um, but still I am helping many journalists tell stories and, uh, I feel kind of like a story midwife in many ways. Just like helping people produce stories and get the, get the quotes, get the angles that need to be discussed, get the sentences structures right, and, um, uh, helping [00:03:00] sometimes in a visionary kind of, uh, mindset. Mary Carreon: So yeah, that's what I'm doing these days. Joe Moore: Oh, there it is. Oh, there you are. Love that. And um, you know, it's important to have, um, editors who kind of really get it from a lot of different angles. I love that we have a lot of alignment on this kind of, and the drug war thing and kind of let's, uh, hopefully start developing systems that are for people. Joe Moore: Yeah, absolutely. If you wanna just say that. Yeah, absolutely. Mary Carreon: Yeah, absolutely. Joe Moore: So, um, yeah, I almost 10 years in January. That's great. We um, it's so crazy that it's been that long. I think we just turned nine and a half, so we're maybe just a few, a few months shorter than your I love it. Plant medicine reporting career. Joe Moore: That's great. I love it. Um, yeah, so I think. I think one of the first times we chatted, [00:04:00] um, I think you were doing a piece about two cb Do you, do you have any recollection of doing a piece on two cb? Mary Carreon: I do, yes. Yes. Wait, I also remember hitting you up during an Instagram live and I was like, are you guys taking any writers? Mary Carreon: And you guys were like writers, I mean, maybe depending on the writer. Joe Moore: And I was like, I was like, I dunno how that works. Mary Carreon: Like me. Yeah. Joe Moore: Yeah. It was fun. It was fun to work with people like yourself and like get pieces out there. And eventually we had an awesome editor for a bit and that was, that was really cool to be able to like support young startup writers who have a lot of opinions and a lot of things to point out. Joe Moore: There's so much happening. Um, there was so much fraud in like wave one. Of kind of the psychedelic investment hype. There's still some, but it's lesser. Um, and it's really a fascinating space still. Like changing lives, changing not just lives, right? Like our [00:05:00] perspective towards nearly everything, right? Joe Moore: Yeah. Mary Carreon: Yes, absolutely. Absolutely. I mean, it's interesting because the space has matured. It's evolved. It's different than it was even, what a, I mean, definitely nine years ago, but even five years ago, even four years ago, even last year, things are different. The landscape is different than it was a year ago. Mary Carreon: And I, it's, it's interesting to see the politics of things. It's interesting to see who has money these days given like how hard it is just to kind of survive in this space. And it's interesting just to. Bear witness to all of this going down because it really is a once in a lifetime thing. Nothing is gonna look the same as it does now, as it, uh, then it will like in a, in a year from now or anything. Mary Carreon: So it's really, yeah. It's interesting to take account of all of this Joe Moore: That's so real. Uh, maybe a little [00:06:00] too real, like it's serious because like with everything that's going on from, um, you know, governance, governments, ai Yes. Drug policy shifts. Drug tech shifts, yes. There's so much interesting movement. Um, yes. Joe Moore: You, you know, you, you kind of called it out and I think it's really actually worth discussing here since we're both here on the air together, like this idea that the psychedelic market, not idea, the lived experience of the psychedelic market having shifted substantially. And I, I, I think there's a lot of causes. Joe Moore: But I've never had the opportunity to really chat with you about this kind of like interesting downturn in money flowing into the space. Mm-hmm. Have you thought about it? Like what might the causes be? I'm sure you have. Mary Carreon: Yeah. Yeah, I have. Yeah. I've thought about it. I mean, it's hard. Well, I don't know. I am really not trying to point fingers and that's not what I'm [00:07:00] trying to do here. Mary Carreon: But I mean, I think a lot of people were really hopeful that the FDA decision last June, not last June, the previous June, a year ago, 2024, June was going to open the floodgates in terms of funding, in terms of, um. In terms of mostly funding, but also just greater opportunities for the space and, uh, greater legitimacy granted to the psychedelic medicine space. Mary Carreon: Mm. And for those who might not know what I'm talking about, I'm talking about the, uh, FDA decision to reject, uh, MDMA assisted therapy and, um, that whole, that whole thing that happened, I'm sure if it, you didn't even have to really understand what was going on in order to get wind of that wild situation. Mary Carreon: Um, so, so maybe, yeah. You probably know what I'm talking about, but I, I do think that that had a great impact on this space. Do I think it was detrimental to this space? [00:08:00] I don't think so. We are in a growth spurt, you know, like we are growing and growing pains happen when you are evolving and changing and learning and figuring out the way forward. Mary Carreon: So I think it was kind of a natural process for all of this and. If things had gone forward like while, yeah, there probably would be more money, there would be greater opportunity in this space for people wanting to get in and get jobs and make a living and have a life for themselves in this, in this world. Mary Carreon: I don't know if it was, I don't know if it would necessarily be for the betterment of the space in general for the long term. I think that we do have to go through challenges in order for the best case scenarios to play out in the future, even though that's difficult to say now because so many of us are struggling. Mary Carreon: So, but I, but I have hope and, and that statement is coming from a place of hope for the future of this space and this culture. Joe Moore: Yeah. It's, um, I'm with [00:09:00] you. Like we have to see boom bust cycles. We have to see growth and contraction just like natural ecosystems do. Mary Carreon: Absolutely, absolutely. It has to be that way. Mary Carreon: And if it's not that way, then ifs, if. It's, it like what forms in place of that is a big bubble or like a, a hot air balloon that's inevitably going to pop, which, like, we are kind of experiencing that. But I think that the, I think that the, um, the, the air letting out of the balloon right now is a much softer experience than it would be if everything was just like a green light all the way forward, if that makes sense. Mary Carreon: So, Joe Moore: right. And there's, there's so many factors. Like I'm, I'm thinking about, uh, metas censorship like we were talking about before. Yes. Other big tech censorship, right? Mm-hmm. SEO shifts. Mary Carreon: Oh. Um, yes, absolutely. Also, uh, there were some pretty major initiatives on the state level that did not pass also this past year that really would've also kind of [00:10:00] helped the landscape a little bit. Mary Carreon: Um. In terms of creating jobs, in terms of creating opportunities for funding, in terms of having more, uh, like the perception of safer money flow into the space and that, you know, those, those things didn't happen. For instance, the measure for in Massachusetts that didn't go through and just, you know, other things that didn't happen. Mary Carreon: However, there have been really good things too, in terms of, uh, legalization or various forms of legalization, and that's in New Mexico, so we can't, you know, forget that there, and we also can't forget just the movement happening in Colorado. So there are really great things happening and the, the movement is still moving forward. Mary Carreon: Everything is still going. It's just a little more difficult than maybe it could have been Joe Moore: right. Yeah. Amen. Amen. Yes. But also, we Mary Carreon: can't forget this censorship thing. The censorship thing is a horse shit. Sorry. I'm not sure if I'm allowed to cuss, but it is, [00:11:00] but it is Joe Moore: calling it out and it's important to say this stuff. Joe Moore: And you know, folks, if you want to support independent media, please consider supporting Doubleblind and psychedelics today. From a media perspective, absolutely. We wanna wanna put as much out as we can. Yes. The more supporters we have, the more we can help all of you understand what's happening and yes. Joe Moore: Getting you to stay safer. Mary Carreon: Yeah, absolutely. And that's the whole difficulty with the censorship is that psychedelics today, and Doubleblind for instance, but also Lucid News, also other, uh, other influencers, other creators in the space, they like. What all of us are doing is putting out information that is ultimately creating a safer user experience. Mary Carreon: And so with the censorship, we are not able to do so anymore, which creates actually a lot of danger. So. Yeah, it's, it's difficult. The censorship is difficult, and if you are somebody who posts about psychedelics, I know that you know this and I am preaching to the choir. Joe Moore: Yeah. So can you talk a [00:12:00] little bit about you all at Double Blind made a major shift in the last number of months towards, uh, kind of not necessarily putting everything out there and, and kind of like, um, actually I don't even know the language you use. Joe Moore: What's the, what's the language you use for the kind of model shift you took on? Mary Carreon: Yeah, I mean, it's great. It's been a wild shift. It's been a wild shift. Um, what we are currently doing is we went to a newsletter first model, which instead of just posting onto a website for everyone to see, and then, um, you know, hopefully getting SEO hits and also posting on their, then posting those stories onto Instagram and Facebook and Twitter, and hoping to get traffic through social media. Mary Carreon: Uh, we decided that that was no longer working for us because it wasn't, um, because the censorship is so bad on, on social media, like on Instagram, for instance, and Facebook and Twitter, well, less on Twitter, [00:13:00] but still, nonetheless on social media, the censorship is so bad. And also the censorship exists on Google. Mary Carreon: When you Google search how to take mushrooms, double blinds is not even on. You know, our guide is not on the first page. It's like, you know, way the heck, way the heck down there. Maybe page 2, 3, 4, 5. I don't know. But, um, the issue, the issue with that, or, or the reason why rather that it's that way is because Google is prioritizing, um, like rehabilitation centers for this information. Mary Carreon: And also they are prioritizing, uh, medical information. So, like WebMD for instance. And all of these organizations that Google is now prioritizing are u are, are, are, are organizations that see psychedelic use through the lens of addiction or through drug drug abuse. So [00:14:00] again, you know, I don't know, take it for how you want to, I'm not gonna say, I'm not gonna tell anybody like what is the right way to use their substances or whatever. Mary Carreon: However, it's really important to have the proper harm reduction resources and tools available. Uh, just readily available, not five pages down on a Google search. So anyways, all of that said double blind was our traffic was way down. And it was looking very bleak for a while. Just we were getting kicked off of Instagram. Mary Carreon: We weren't getting any traffic from social media onto our website, onto our stories. It was a, it was a vicious kind of cycle downward, and it wasn't really working. And there was a moment there where Doubleblind almost shut down as a result of these numbers because there's a, like you, a media company cannot sustain itself on really low page views as a result. Mary Carreon: So what we [00:15:00] decided to do was go to a newsletter first model, which relies on our email list. And basically we are sending out newsletters three days a week of new original content, mostly, uh, sometimes on Wednesdays we repost an SEO story or something like that. Um, to just to engage our audience and to work with our audience that way, and to like to actually engage our audience. Mary Carreon: I cannot emphasize that enough because on Instagram and on Facebook, we were only reaching like, I don't know, not that many people, like not that many people at all. And all of that really became obvious as soon as we started sending out to our email list. And as soon as we did that, it was wild. How many, how many views to the website and also how many just open like our open rate and our click through rate were showing how our audience was reacting to our content. Mary Carreon: In other words. [00:16:00] Social media was not a good, in, like, was not a good indicator of how our content was being received at all because people kind of weren't even receiving it. So going to the newsletter first model proved to be very beneficial for us and our numbers. And also just reaching our freaking audience, which we were barely doing, I guess, on social media, which is, which is wild, you know, for, for a, an account that has a lot of followers, I forget at this exact moment, but we have a ton, double blind, has a ton of followers on, on Instagram. Mary Carreon: We were, we, we get like 500 likes or, you know, maybe like. I don't know. If you're not looking at likes and you're looking at views, like sometimes we get like 16 K views, which, you know, seems good, but also compared to the amount of followers who follow us, it's like not really that great. And we're never reaching new, like a new audience. Mary Carreon: We're always reaching the same audience too, [00:17:00] which is interesting because even with our news, with our, with our email list, we are still reaching new people, which is, which says just how much more fluid that space is. Mm-hmm. And it's because it's, because censorship does not at least yet exist in our inboxes. Mary Carreon: And so therefore email is kind of like the underground, if you will, for this kind of content and this type of material journalism, et cetera. So, so yeah. So it, it, it has been a massive shift. It is required a lot of changes over at double blind. Everything has been very intense and crazy, but it has been absolutely worth it, and it's really exciting that we're still here. Mary Carreon: I'm so grateful that Double-Blind is still around, that we are still able to tell stories and that we are still able to work with writers and nurture writers and nurture the storytelling in this space because it needs to evolve just the same way that the industry and the [00:18:00] culture and everything else is evolving. Joe Moore: Yeah, I think, I think you're spot on like the, when I watch our Instagram account, like, um, I haven't seen the number change from 107 K for two years. Mary Carreon: Absolutely. Same. And, um, same. Joe Moore: Yeah. And you know, I think, I think there's certain kinds of content that could do fine. I think, uh, psychedelic attorney, Robert Rush put up a comment, um, in response to Jack Coline's account getting taken down, um, that had some good analysis, um. Joe Moore: Of the situation. Go ahead. You had No, Mary Carreon: no, I'm just like, you know, I can't, when, when journalists are getting kicked off of these, of these platforms for their stories, for their reported stories, that's like, that is a massive red flag. And that's all I have to say. I mean, we could go into more, more details on that, but that is a [00:19:00] huge red flag. Joe Moore: Mm-hmm. Yeah. Um, for sure. The, I, yeah. And like I'm sure he'll get it back. I'm sure that's not for good, but I think he did. Okay, great. Mary Carreon: I think he did. Yeah. Yeah, I think he did. Joe Moore: Yeah. So thank you. Shout out to Jack. Yeah, thanks Jack. Um, and I think, you know, there's, there's no one with that kind of energy out there. Joe Moore: Um, and I'm excited to see what happens over time with him. Yeah. How he'll unfold. Absolutely unfold. Oh yeah. It's like, um. Crushing the beat. Mary Carreon: Oh yeah, absolutely. Especially the political, the political beat. Like, there's no, there's few people who are really tackling that specific sector, which is like mm-hmm. Mary Carreon: So exciting for a journalist. Joe Moore: Yeah. Um, so model shifting, like we all have to like, adapt in new ways. Kyle and I are still trying to figure out what we're gonna do. Like maybe it is newsletter first. Like I, I realized that I hadn't been writing for [00:20:00] years, which is problematic, um, in that like, I have a lot of things to say. Mary Carreon: Totally. Joe Moore: And nobody got to hear it. Um, so I started a substack, which I had complicated feelings about honestly. 'cause it's just another. Rich person's platform that I'm, you know, helping them get Andreessen money or whatever. And, you know, so I'm gonna play lightly there, but I will post here and there. Um, I'm just trying to figure it all out, you know, like I've put up a couple articles like this GLP one and Mushrooms article. Mary Carreon: I saw that. I saw that. Really? And honestly, that's a really, like, it's so weird, but I don't, like, it's such a weird little thing that's happening in the space. I wonder, yeah, I wonder, I wonder how that is going to evolve. It's um, you know, a lot of people, I, I briefly kind of wrote about, um, psychedelics and the GLP, is that what it is? Mary Carreon: GLP one. Joe Moore: GLP one. Say Ozempic. Yeah, just, yeah, Ozempic. Yeah, exactly. Mary Carreon: Yeah, exactly. I wrote about [00:21:00] that briefly last year and there were a bunch of people like obviously horrified, which it is kind of horrifying, but also there's a bunch of people who believe that it is extremely cutting edge, which it also is. Mary Carreon: So it's really interesting, really fascinating. Joe Moore: Yeah. Um, I remember Bernie Sanders saying like, if this drug gets as much traction as it needs to, it will bankrupt Medicaid. I guess that's not really a problem anymore. Um, but, but, uh, but so like naming it real quick, like it changed the way we had to digest things, therefore, like mushrooms get digested differently and, um, some people don't respond in the expected ways. Joe Moore: And then there was some follow up, oh, we, in the regulated model, we just do lemon tech. And then I was like, is that legal in the regulated model? And I, I don't know the answer still. Mm-hmm. Like there was a couple things, you know, if users know to do it, you know, I don't, I don't totally understand the regulated model's so strange in Oregon, Colorado, that like, we really need a couple lawyers opinions. Joe Moore: Right. I think Mary Carreon: yes, of course Joe Moore: the lawyers just gave it a [00:22:00] thumbs up. They didn't even comment on the post, which is, laughs: thanks guys. Um, Joe Moore: but you know, laughs: yeah. You're like, thank you. Joe Moore: Thanks and diversity of opinions. So yeah, there's that. And like GLP ones are so interesting in that they're, one friend reached out and said she's using it in a microdose format for chronic neuroinflammation, which I had never heard of before. Joe Moore: Whoa. And um, I think, you know, articles like that, my intent was to just say, Hey, researchers yet another thing to look at. Like, there's no end to what we need to be looking at. Abso Mary Carreon: Oh, absolutely, absolutely. You know, reporting on this space actually taught me that there's so much just in general that isn't being researched, whether that's in this space, but also beyond and how, um, yeah, just how behind, actually, maybe not, maybe behind isn't the right word, but it kind of feels from my novice and from my novice place in the, in the world and [00:23:00] understanding research, it's. Mary Carreon: Hard for me to see it as anything, but being behind in the research that we all really need, that's really going to benefit humanity. But also, you know, I get that it's because of funding and politics and whatever, whatever, you know, we can go on for days on all of that. Joe Moore: What's the real reason? What's the real reason? Joe Moore: Well, drug war. Mary Carreon: Yeah. Well, yeah, definitely the drug war. Nixon. Yeah. Yes, yes, definitely the drug war. Yeah. I mean, and just the fact that even all of the drug research that happens is, again, through the lens of addiction and drug abuse, so Joe Moore: mm-hmm. Hard to right. Yeah. Um, like ni a is obviously really ridiculous and, and the way they approach this stuff, and Carl Hart illustrates that well, and, Mary Carreon: oh man, yes, he does. Joe Moore: Like, I think Fadiman's lab in Palo Alto got shut down, like 67, 66 or 67, and like that's, you know, that was one of the later ones, Mary Carreon: right? And, Joe Moore: and like, Mary Carreon: and here we are. Joe Moore: The amount of suffering that could have been alleviated if we [00:24:00] had not done this is. Incalculable. Um, yes. Yes. Yeah. Mary Carreon: I mean the, yeah, it's hard to say exactly how specifically it would be different, but it's difficult to also not think that the fentanyl crisis and the opioid addiction rate and situation that is currently like plaguing the, the world, but particularly the United States, it's hard to think that it wouldn't be, like, it wouldn't be a different scenario altogether. Joe Moore: Right, right. Absolutely. Um, and it's, um, it's interesting to speculate about, right? Like Yeah. Yes. Where would we be? And Mary Carreon: I know, I know, I know, I know it is speculation. Absolutely. But it's like hard, as I said, it's hard not to think that things would be different. Joe Moore: Right. Right. Um, I like, there's two kind of quotes, like, um, not, this one's not really a quote. Joe Moore: Like, we haven't really had a [00:25:00] blockbuster psychiatric med since Prozac, and I think that was in the eighties or early nineties, which is terrifying. And then, um, I think this guy's name is James Hillman. He is kinda like a Jungian, um, educator and I think the title of one of his books is, we're a hundred Years Into Psychotherapy and the World is Still a Mess. Joe Moore: And I think like those two things are like, okay, so two different very white people approaches didn't go very far. Yes. Um, yes and laughs: mm-hmm. Joe Moore: Thankfully, I think a lot of people are seeing that. Mm-hmm. Um, finally and kind of putting energy into different ways. Um, Mary Carreon: yeah. Absolutely. I think, yeah, I mean, we need to be exploring the other options at this point because what is currently happening isn't working on many fronts, but including in terms of mental health especially. Mary Carreon: So mm-hmm. We gotta get going. Right? We [00:26:00] gotta get moving. Geez. Joe Moore: Have you all, have you all seen much of the information around chronic pain treatments? Like I'm, I'm a founding board member with the Psychedelics and Pain Association, which has a really fun project. Oh, that's interesting. Mary Carreon: Um, I've seen some of the studies around that and it's endlessly fascinating for obvious, for obvious reasons. Mary Carreon: I, um, we have a writer who's been working for a long time on a story, uh, about the chronic pain that has since. Become an issue for this, for her, for the writer. Mm-hmm. Um, since she had COVID. Mm-hmm. Since, since she is just like, COVID was the onset basically of this chronic pain. And, um, there she attended a psychedelics in pain, chronic pain conference and, uh, that has pretty much like, changed her world. Mary Carreon: Um, well, in terms of just the information that's out there, not necessarily that she's painless, but it's just, you know, offering a, a brand new, a brand new road, a brand new path that is giving her, [00:27:00] um, relief on days when the pain is, uh, substantial. laughs: Yeah. Mary Carreon: So that's interesting. And a lot of people are experiencing that as well. Joe Moore: Mm-hmm. So there's, there's a really cool set of overlap between the COVID researchers, long COVID researchers and the chronic pain people. 'cause there is Yes. This new science of pain that's yes. Our group, PPA put out like a really robust kind of training, um, for clinicians and researchers and even patients to get more educated. Joe Moore: And we're, we're getting, um, kind of boostered by cluster busters and we're kind of leveraging a lot of what they've done. Mary Carreon: Wait, what is a cluster buster? Joe Moore: Oh gosh. Um, so they're a 5 0 1 C3. Okay. Started with Bob Wald. Okay. Bob Wald is a cluster headache survivor. Oh, oh, oh, Mary Carreon: okay. Got it. Got it. Yes. So they're Joe Moore: the charity that, um, has been really championing, um, cluster headache research because they found a protocol [00:28:00] with mushrooms. Joe Moore: Yes, yes, yes. To eliminate. Mm-hmm. Yeah. Um, this really great, I Mary Carreon: love that. Joe Moore: This really great book was written by a Rutgers, um, I think medical sociologist or anthropologist psychedelic. Love laughs: that. Joe Moore: Joanna Kempner. Cool. Um, and it kind of talks about the whole, um, cluster busters saga, and it was, it was pretty cool. Joe Moore: Nice. So they've been at it for about as long as maps. Um, oh wow. Maybe a little earlier. Maybe a little later. Mary Carreon: I love that. Cool. I mean, yeah, that's really great. That's really great. Joe Moore: So we're copying their playbook in a lot of ways and Cool. We about to be our own 5 0 1 C3 and, um, nice. And that should be really fun. Joe Moore: And, uh, the next conference is coming up at the end of next month if people wanna check that out. Psychedelic. Nice. Mary Carreon: Nice, nice, nice. Cool. Joe Moore: Yeah, so that, like, how I leaned into that was not only did I get a lot of help from chronic pain with psychedelics and going to Phish shows and whatever, um, you know, I, and overuse for sure helped me somehow. Joe Moore: [00:29:00] Um, God bless. Yeah. But I, I like it because it breaks us out of the psychiatry only frame for psychedelics. Mm. And starts to make space for other categories. Mm-hmm. Is one of the bigger reasons I like it. Mary Carreon: Mm-hmm. Mm-hmm. Yes. Yes. Which, like, we need to be, we need to, we, no one else is gonna do it for us. We like the people in the space who are finding new uses for these substances need to be creating those, those pathways and those new niches for people to then begin studying, et cetera, and exploring and yeah. Mary Carreon: Making, making a proper avenue for, Joe Moore: right, right. And, you know, um, I don't know that this is a Maha thing, so No, I'm going there, I guess, but like, how do we kind of face squarely America and the world's drinking problems? Not [00:30:00] knowing what we know now about alcohol, you know what I mean? And then like, what are the alternatives? Joe Moore: You know, some, some writers out there on substack are very firm that everybody needs to not do any substance. And like all psychedelics are super bad and drugs are evil, you know, famous sub stackers that I won't name. But you know, like what is the alternative? Like, I, like we have to have something beyond alcohol. Joe Moore: And I think you've found some cannabis helpful for that. Mary Carreon: Yeah, I, you know, it's, it's interesting because it's, there are, there's definitely an argument to be made for the power of these substances in helping, I don't wanna, I don't wanna say curb, but definitely reduce the symptoms of, uh, wanting to use or to drink or to consume a specific substance. Mary Carreon: There's obviously there is an argument to be made. There are, there is ano another camp of people who are kind [00:31:00] of in the, in the, in the, in the realm of using a drug to get off of a drug isn't how you do it. However, and, and I do, it depends on the individual. It depends on the individual and the, and how that person is engaging with their own addiction. Mary Carreon: I think for whether or not the substances work, like whether psychedelics work to help somebody kind of get off of alcohol or get off of cocaine or stop using opioids or, you know, et cetera. Mm-hmm. However, I think like, when the situation is so dire, we need to be trying everything. And if that means, like, if, like, you know, if you look at the studies for like smoking cessation or alcohol use, mushrooms do help, psilocybin does help with that. Mary Carreon: Mm-hmm. But, you know, there's, there's a lot of, there's a lot of things that also need to happen. There's a lot of things that also need to happen in order for those, uh, that relief to maintain and to stick and to, uh, really guide [00:32:00] somebody off of those substances. Mm-hmm. It's not just the substance itself. Joe Moore: Right. So I'm, I'm explicitly talking like recreational alternatives, right. Like how do I Yeah. On per minute, like, am Anitas becoming helpful? Yeah, yeah. Are helpful and Yeah. Yeah. I think like even, um, normal. What we might call like normal American alcohol use. Like Yeah. That's still like, quite carcinogenic and like, um, absolutely. Joe Moore: We're kind of trying to spend less as a country on cancer treatments, which I hope is true. Then how do we, how do we develop things that are, you know, not just abstinence only programs, which we know for sure aren't great. Mary Carreon: Yeah. They don't work. Yeah. I don't, it's, it's difficult. Mm-hmm. It's difficult to say. Mary Carreon: I mean mm-hmm. I don't know. Obviously I, I, well, maybe it's not obvious at all for people who don't know me, but, you know, I exist in a, I exist in, in a world where recreational use is like, it's like hard to define what recreational use is because if we are using this, if we are using mushrooms or LSD even, or MDMA, [00:33:00] you know, there are so many, there's a lot of the therapy that can happen through the use of these substances, even if we're not doing it, you know, with a blindfold on or whatever and yeah, I think like. Mary Carreon: There is a decent swap that can happen if you, if you are somebody who doesn't wanna be, you know, having like three beers a night, or if you are somebody who's like, you know, maybe not trying to have like a bottle of wine at a night or something like that, you know, because like Americans drink a lot and a lot of the way that we drink is, um, you know, like we don't see it as alcoholism. Mary Carreon: Even though it could be, it could be that's like a difficult Joe Moore: potentially subclinical, but right there. Mary Carreon: Um, yeah. Yeah. It's like, you know, it's, um, we don't see it as that because everybody, a lot of people, not everybody, but a lot of people drink like that, if that makes sense. If you know mm-hmm. If you, if you get what I'm, if you get what I'm saying. Mary Carreon: So, you know, I do think that there's a lot of benefit that, I don't [00:34:00] know, having, like a, having a mushroom, having a mushroom experience can really help. Or sometimes even like low dose, low doses of mushrooms can also really help with, like, with the. Desire to reach for a drink. Yeah, totally. And, and AMS as well. Mary Carreon: I know that that's also helping people a lot too. And again, outside of the clinical framework. Joe Moore: Yeah. I'm, a lot of people project on me that I'm just like constantly doing everything all the time and I'm, I'm the most sober I've been since high school. You know, like it's bonkers that like Yeah. Um, and you know, probably the healthiest event since high school too. Joe Moore: Yeah. But it's fa it's fascinating that like, you know, psychedelics kind of helped get here and even if it was like For sure something that didn't look like therapy. Yeah, Mary Carreon: yeah, yeah, yeah. Absolutely. Absolutely. Yeah. I, I think, I think most of us here in this space are getting projected on as to like, you know, being like what Normies would consider druggies or something, or that we are just like, you know, high all the time. Mary Carreon: Um, [00:35:00] I know that that is definitely something that I face regularly, like out in the world. Um, but, you know, I would also, I would also argue that. Uh, like mushrooms have completely altered my approach to health, my approach to mental health, and not even having to consume that, you know, that substance in order or that, you know, that fun fungi, in order for me to like tap into taking care of my mental health or approaching better, uh, food options, et cetera. Mary Carreon: It's kind of like what these, it's like how the mushrooms continue to help you even after you have taken them. Like the messages still keep coming through if you work with them in that capacity. Right. And yeah, and also same with, same with LSD too. LSD has also kind my experiences with that have also guided me towards a healthier path as well. Mary Carreon: I, I understand that maybe for some people it's not that way, but, um, for me that substance is a medicine as well, [00:36:00] or it can be. Joe Moore: Yeah. Um, so. What are, what are some things popping up these days about like US drug policy that's like getting exciting for you? Like, are you feeling feeling like a looming optimism about a, a major shift? Joe Moore: Are you kind of like cautiously optimistic with some of the weird kind of mandatory minimum stuff that's coming up or? Mary Carreon: Yeah. Yeah. I mean, I know that there was a huge, a, a pretty huge shift over at the DEA and I wish I remembered, I wish I remembered his name. The new guy who's now, I believe the head of the DEA, I don't know enough information about it to really feel a way. Mary Carreon: However, I don't think that he's necessarily going to be serving us as a community here, uh, in the psychedelic space. I, you know, I just don't think that that's something that we can ever depend on with the DEA. Uh, I also don't think that [00:37:00] the DEA is necessarily going to be. All that helpful to cannabis, like the cannabis space either. Mary Carreon: Um, I know that, that Trump keeps kind of discussing or, or dangling a carrot around the rescheduling of cannabis. Um, for, he's been, he's been, but he's doing it a lot more now. He's been talking about it more recently. Uh, he says like, in the next like couple weeks that he's going to have some kind of decision around that, allegedly. Mary Carreon: But we will see also, I'm not sure that it's going to necessarily help anybody if we reschedule two. Uh, what from schedule one to schedule th two, three, schedule three. Joe Moore: Either way it's like not that useful. Right. Exactly. Mary Carreon: Yeah. Yeah, exactly. It's, um, just going to probably cause a lot more red tape and a lot of confusion for the state rec markets. Mary Carreon: So it's like something that we, it's like only ridden with unintentional, unintentional consequences. Unintended consequences. Mm-hmm. Because no one knows how it's really going to [00:38:00] impact anything, um, if, if at all. But I don't know. It's hard, it's hard to imagine that there won't be any, uh, like more complex regulatory issues for business owners and also probably consumers as well. Joe Moore: Hmm. Yeah. This guy's name's Terry Cole. Mary Carreon: Oh, the new DEA guy. Joe Moore: Yeah. Um, I don't know much about him. Terry. Yeah. Terry, I would love to chat. Mary Carreon: Yeah. Terry, let's talk. I'm sure your people Joe Moore: are watching. Yeah. So like, just let him know. We wanna chat. Yeah. We'll come to DC and chat it out. Um, yeah. It's, um, but yeah, I, Carl Hart's solution to me makes like almost most of the sense in the world to just end the scheduling system Absolutely. Joe Moore: And start building some sort of infrastructure to keep people safe. That's clearly not what we have today. Mary Carreon: No. But building an infrastructure around the health and wellness and uh, safety of [00:39:00] people is the exact opposite system that we have currently right now. Because also the scheduling system has a lot to do with the incarceration in the United States and the criminal just, or the criminal system. Mary Carreon: So, so yeah, like we can't disentangle the two really. Joe Moore: It just started, um, I feel negligent on this. Uh, synergetic press put out a book like a year or two ago called Body Autonomy. Mm-hmm. Um, did that one come across your desk at all? Mm-hmm. No. I wish basically contributed. Oh, nice. A number of people. So it's both like, um. Joe Moore: Drug policy commentary and then like sex work commentary. Oh, nice. And it was like high level, like love that really, really incredible love that detailed science based conversations, which is not what we have around this. Like, that doesn't make me feel good. So you should go to jail kind of stuff. Or like, I'm gonna humiliate you for real though. Joe Moore: Ticket. Yeah, Mary Carreon: yeah, yeah, yeah, yeah. Oh God. Uh, when you think about it like that, it just really also shows [00:40:00] just the uh, um, the level at which religion has also kind of fundamentally infused itself into the scheduling system, but also our laws, you know, like what you just said, this like, shame-based, I'm going to embarrass you and make you into a criminal when you know actually you are a law for the most part, a law abiding citizen, with the exception of this one thing that you're doing for. Mary Carreon: A, your survival and or your, like, your feeling good, wanting to feel good addressing pain. Um, there's a large, uh, like noise coming out of the front yard of my house right now. Hold on. Just a, it doesn't sound too bad. It doesn't sound too bad. Okay. Okay, good. Not at all. Not at all. Okay. Yeah, I had Joe Moore: people working on my roof all day and somehow it worked out. Joe Moore: Oh, good. Um, yeah. Um, yeah, it's, it's fascinating and I, I've been coming around like, I, I identify as politically confused, [00:41:00] um, and I feel like it's the most honest way I can be. Um, Mary Carreon: I am also politically confused these days, impossible to align with any, uh, party or group currently in existence at this exact juncture in American history. Joe Moore: I can't find any that I want to throw my dice in with. Nah. This idea of like fucking way being. Like what is the most humane way to do government as a way it's been put to me recently. And that's interesting. So it comes down to like coercion, are we caring for people, things like that. And um, I don't think we're doing it in a super humane way right now. Mary Carreon: Um, we, yeah, I am pretty sure that even if there was, I mean, I think that even if we looked at the data, the data would support that we are not doing it in a humane way. Joe Moore: So Mary Carreon: unfortunately, and Joe Moore: you know, this whole tech thing, like the tech oligarch thing, you kind of dropped at the beginning and I think it's worth bringing that back because we're, we're on all [00:42:00] these tech platforms. Joe Moore: Like that's kind of like how we're transmitting it to people who are participating in these other platforms and like, you know, it's not all meta. I did turn on my personal Facebook, so everybody's watching it there. I hope. Um, see if that count gets, Mary Carreon: um, Joe Moore: but you know, this idea that a certain number of private corporations kind of control. Joe Moore: A huge portion of rhetoric. Um, and you know, I think we probably got Whiffs of this when Bezos bought Washington Post and then Yes. You know, Musk with X and like yes. You know, is this kind of a bunch of people who don't necessarily care about this topic and the way we do, and they're like in larger topics too about humane government and like, you know, moving things in good directions. Joe Moore: Um, I don't know, thoughts on that rift there as it relates to anything you, wherever you wanna go. Yeah. Mary Carreon: Yeah. I mean, I don't think that they are looking at, I don't think that they are looking [00:43:00] at it the way that we are. I don't think that they can see it from their vantage point. Um, I think that like, in the, in a similar way that so many CEOs who run businesses have no fucking clue about what's actually happening in their businesses and the actual workers and, and employees of their businesses can tell them in more detail. Mary Carreon: Far more detail about what's actually happening on the, on the floor of their own business. Uh, I think that it is something like that. However, that's not to say that, you know, these, these CEOs who employ people who build the A algorithm are obviously guided to create the limitations on us as people who speak about drugs, et cetera, and are creating a algorithm that ultimately is looking at things in a very blanket way in terms of, uh, like we're probably seen on the same level as like drug dealers, if that makes sense. Mary Carreon: Which is obviously a much, you know, there's, [00:44:00] it's a very different thing. Um, so, you know, there's like these CEOs are giving directions to their employees to ultimately create systems that harm. Information flow and inform and, and like the information health of, of platforms and of just people in general. Mary Carreon: So it's hard to say because there's nuance there, obviously, but I would bet you that someone like Elon Musk doesn't really have a full grasp as to the, the nuances and details of what's even happening within, on the ground floor of his businesses. Because that's like, not how CEOs in America run, run, and operate. Mary Carreon: They're stupid companies. So, so yeah. And I feel like that, like, that's across the board, like that's across the board. That's how I, that's probably how Zuck is operating with Meta and Facebook, et cetera. And yeah, just likewise and across, across the whole, [00:45:00] across the whole spectrum. Joe Moore: Mm-hmm. Yeah. And I think, um, a thing. Joe Moore: Then as the people like, we need to keep looking at how can we keep each other informed. And that's kind of circling back to drug journalism like we do and like, um, other, other sorts of journalism that doesn't really get the press it deserves. Right. And I've been getting far more content that I find more valuable off of tragically back on Zucks platform like IG is getting me so much interesting content from around the world that no major outlet's covering. Mary Carreon: That's so interesting. Like what? Like what would you say? Joe Moore: Oh, um, uh, certain, um, violent situations overseas. Oh, oh, got it. Yeah, yeah, yeah. And, um, you know, that America's paying for, so like, you know, I just don't love that I don't have a good, you know, journalistic source I can [00:46:00] point to, to say, hey, like right. Joe Moore: These writers with names, with addresses, like, and offices here. Yes. You know, they did the work and they're held, you know, they're ethical journalists, so yes. You can trust them. Right. You know what I mean? Yes, Mary Carreon: yes. Yeah, yeah, yeah. I mean, all of this makes everything so much harder for determining, like, the censorship specifically makes it so much harder for the people to determine like, what's real, what's not. Mary Carreon: Because, because of exactly what you just said. Mm-hmm. Like, you know, we are, we are basically what that means, like what is required of the people and people who are consuming information is becoming a smart consumer and being able to determine what's real, what's not. How can we trust this individual? Mary Carreon: How can we not, which isn't analysis process that all of us need to be sharpening every single day, especially with the advent of AI and, uh, how quickly this, this type of content is coming at all of us. Like, especially if you're on TikTok, which many of us are, you know, like information comes flying at you 3000 miles an hour, and it's sometimes [00:47:00] really difficult to determine what's real, what's not, because AI is. Mary Carreon: AI is not where it's going to be, and it still is in its nascent phase. However, it's still pretty fucking good and it's still very confusing on there. So, so again, like the media literacy of the people needs to be sharpened every single day. We cannot be on there, we cannot be on the internet existing. Mary Carreon: That everything that we are seeing is real. Whether that's about, you know, these, um, the violence overseas, uh, happening at the hands of the United States, whether that is, uh, even drug information like, you know, et cetera, all of all of it. Or just like news about something happening at Yellowstone National Park or something that is happening in the, uh, at like. Mary Carreon: Um, like potential riots also happening at protests in downtown la, et cetera. Like all, all of it, we need to be so careful. And I think what that also, like, one way that [00:48:00] we can adjust and begin to develop our media literacy skills is talking to people maybe who are there, reaching out to people who are saying that they were there and asking them questions, and also sussing that out. Mary Carreon: You know, obviously we can't do that for all situations, but definitely some of them. Joe Moore: Yeah, absolutely. Like, Joe Moore: um, a quick pivot. Mm-hmm. Were you at PS 25? Mary Carreon: Yes, I was. What did I think? Uh, you know, I, I was running around like crazy at this one. I felt like I didn't even have a second to breathe and I feel like I didn't even have a second to really see anybody. I was like, worry. I was jumping from one stage to the next. Mary Carreon: However, I would say, uh, one of, one of the things that I have said and how I felt about it was that I felt that this, this event was smaller than it was two years ago. And I preferred that I preferred the reduction in size just because it was, uh, less over, less overwhelming [00:49:00] in an, in an already very overwhelming event. Mary Carreon: Um, but I thought that from the panels that I did see that everyone did a really great job. I thought that maps, you know, it's impressive that maps can put on an event like that. Um, I also was very cognizant that the suits were there in full effect and, uh, you know, but that's not unusual. That's how it was last time as well. Mary Carreon: And, um, I felt that there was Mary Carreon: a, uh, like the, the, the level of excitement and the level of like opportunity and pro, like the prosperous. The like, prospect of prosperity coming down the pipeline like tomorrow, you know, kind of vibe was different than last time. Mm-hmm. Which that was very present at the one, two years ago, uh, which was the last PS psychedelic science. Mary Carreon: Yeah. Um, anyways. Yeah. But it was, you know, it was really nice to see everybody. [00:50:00] I feel like in-person events is a great way for everybody in the psychedelic space to be interacting with each other instead of like keyboard warrioring against each other, you know, uh, over the computer and over the internet. Mary Carreon: I think that, um, yeah, uh, being in person is better than being fighting each other over the internet, so, yeah. Joe Moore: Mm-hmm. People seem to be a little bit more civil in person. Mary Carreon: Exactly. Exactly. Mm-hmm. And I think that that is something that we all need to be considering more often, and also inviting people from across the aisle to your events and creating peace, because in person it's a little different than it is. Mary Carreon: When you have the opportunity to, uh, yeah, like keyboard attack someone over the internet, it's like, yeah. It's just so silly. So silly. We look like fools. Like we look like absolute idiots doing that. And you know what? I cannot sit here and say that I haven't looked like an idiot. So, you know, it's like I'm not, I'm not talking from like a high horse over here, but, but you know, it's like, it's [00:51:00] better when it's in person. Mary Carreon: I feel like there's like more civil engagements that we can all have. Joe Moore: It's practice, you know? Yeah. We're learning. Yeah. We are. We should be learning, including us, and yes, of course. Um, I, I play a subtler game these days and, uh, you know, I, I, I, it's better when we all look a lot better in my opinion, because yes, we can inform policy decisions, we can be the ones helping inform really important things about how these things should get implemented and absolutely right. Joe Moore: Like, Mary Carreon: absolutely. Yeah, it does. It does. Nobody, any service, especially these medicines, especially these sacraments, especially these plants, these molecules, et cetera, if we are all sitting here fighting each other and like calling each other names and trying to dunk on one another, when like in reality, we are also all kind of pushing for the same thing more or less. Joe Moore: Mm-hmm. So a thing that [00:52:00] I, it's a, it's kind of a, I, I had a great time at PS 25. I have no, no real complaints. I just wish I had more time. Yeah, same. Um, same. Yeah. Our booth was so busy. It was so fun. Just good. And it was like, good. I, I know. It was really good. I'm trying to say it out loud. I get to talk at the conference before Rick did. laughs: Oh, oh, Joe Moore: the morning show they put us on at like seven 30 in the morning or something crazy. Oh my god. It was early. I dunno if it was seven 30. Mary Carreon: That's so early. That's so early. Joe Moore: Yeah, right. Like that's crazy. I got zero nightlife in That's okay. Um, I was not, I was there for work. Yeah, Mary Carreon: yeah. I was Joe Moore: jealous. I didn't party, but you know, whatever. Joe Moore: Yeah, yeah. Mary Carreon: I did not party this time really in the same way that I did at PS 20. Was it 2023? Joe Moore: 23, yeah. 23. I only stay up till 11 one night in 23. Nice. Mary Carreon: Okay. Um, okay. Joe Moore: So I behaved, I have a pattern of behaving. 'cause I like That's good. I'm so bent outta shape inside going into these things. I'm like, I know, I know. Joe Moore: And, and I'm like, oh, all [00:53:00] my friends are gonna be there. It's gonna be great. And then it's like, yeah. It's mostly friends and only a little bit of stress. Yeah. Um, yeah. Yeah, Mary Carreon: yeah. I had a, I had a great time. It was really good seeing everybody again. Like you, I wish that I had more time with people. Like there are people that I like didn't even see who are my friends, Joe Moore: so, which Yeah. Joe Moore: Which is sad. That's like a subtext in, in like the notes coming away from 25. Is that the, um, American Right, if we wanna call it that, is very interested in this stuff. Oh yeah. Like the Texas establishment. Oh yeah. Um, the Texas contingent, right? They're deep. They're real deep. Mm-hmm. I have, um, Mary Carreon: let's talk about that more. Mary Carreon: Yeah. So Joe Moore: it's optimistic in, in some sense that psychedelic science is getting funded more. By states. 'cause the feds aren't stepping up. Right. I love that. Right. Yeah. Like, Hey feds, look what we can do. And you can't somehow, and [00:54:00] then, um, we'll see if state rights stays around for a while longer, maybe, maybe not. Joe Moore: And then the other part is like, is there a slippery slope given the rhetoric around addiction and the rise in interest in iboga for compulsory addiction treatment with psychedelics or, or compulsory mental health treatments with psychedelics because of the recent, it's illegal to be a person without housing. Joe Moore: Um, and you're gonna get put in treatment. Mm. Like, that's now a thing. So like, I don't know, I don't think forced treatment's good at all. I, and I don't think like, um, like the data is something like 15% effective, maybe less. Right. Right. It's not a good use of money. I don't know. We're, let's, I. You can go there if you want, and riff on that, or if you wanna talk about like, Texas, um, Arizona more generally. Mary Carreon: Yeah. I mean, I will just say this, I also don't really believe that forced treatment is like good, you [00:55:00] know, data Joe Moore: says it's bad. Mary Carreon: Yeah. Yeah. I also, yeah, I mean, it's like, I don't know. Yeah, that's, it's complex. It's a complex issue. I also don't think it's good, but I also do think that we need a much better framework and foundation for like, if people do want the help, helping them get it. Mary Carreon: Much more easily and in a way that's going to be beneficial for them. Um, and I don't think that that system or that pathway currently exists as we saw in, uh, with, with, um, measure 1 0 9 and the failure of measure 1 0 9 or, or was it Measure 1 0 10, 1 10, measure one 10 in Oregon. Joe Moore: But did you see the response yesterday or two days ago? Joe Moore: No, I didn't. No, I didn't. I'll I'll send it to you later. Okay. So the university did the research, um, Portland State University did the research Yes. And said, Hey, look, there was actually 20 other things that were higher priority. Like that actually influenced this increase in overdoses, not our law. Mary Carreon: Right. Mary Carreon: Yes. It was really COVID for Okay. [00:56:00] Like for, yeah. Right. Absolutely. Also, there was not a. Like there was not a framework in place that allowed people to get off the street should they want to, or you know, like, like you just can't really have a, all drugs are legal, or small amounts of drugs are legal without also offering or creating a structure for people to get help. Mary Carreon: That, that's, you can't do one without the other. Unfortunately. That's just like a, that's faulty from the start. So that's all I'll really say about that. And I don't think that that had fully been implemented yet, even though it was something that wasn't ideal for the, um, for the, for the measure. And I believe it was measure one 10, not measure 1 0 9, to be clear. Mary Carreon: Measure one 10. Um, yes, but confirmed one 10 confirmed one 10, yes. Mm-hmm. Um, but yeah, uh, that's, you know, that's kind of what I'll say. That's what I'll, that's where I'll leave that portion. Mm-hmm. You know? Uh, but yeah, forced treatment. I don't know. [00:57:00] We can't be forcing, forcing people to do stuff like that. Mary Carreon: I don't know. It's not gonna, it's, yeah, it doesn't seem Joe Moore: very humane. Mary Carreon: Yeah. No. And it also probably isn't gonna work, so, Joe Moore: right. Like, if we're being conservative with money, like, I like tote, like to put on Republican boots once in a while and say like, what does this feel like? And then say like, okay, if we're trying to spend money smartly, like where do we actually get where we want to be? Joe Moore: And then sometimes I put on my cross and I'm like, okay, if I'm trying to be Christian, like where is the most, like, what is the most Christian behavior here in terms of like, what would the, you know, buddy Jesus want to do? And I'm just like, okay, cool. Like, that doesn't seem right. Like those things don't seem to align. Joe Moore: And when we can find like compassionate and efficient things, like isn't that the path? Um, Mary Carreon: compassionate and t. Yeah, even, I don't know, I don't know if it looks lefty these days, but Yeah, I know what you mean. Yeah, I know what you mean. I know what you mean. Yeah. [00:58:00] Yeah. Um, yeah, it's complicated. It's complicated, you know, but going back, kind of, kind of pivoting and going back to what you were talking about in regards to the subtext, some of the subtext of like, you know, where psychedelic medicine is currently getting its most funding. Mary Carreon: You know, I do believe that that was an undercurrent at psychedelic science. It was the, the iboga conversation. And there's, there's a lot, there's a lot happening with the Iboga conversation and the Iboga conversation and, um, I am really trying to be open to listening to everyone's messages that are currently involved in. Mary Carreon: That rise of that medicine right now? Um, obviously, yeah, we will see, we'll see how it goes. There's obviously a lot of people who believe that this is not the right move, uh, just because there's been no discussions with, uh, the Wii people of West Africa and, you know, because of [00:59:00] that, like we are not talking to the indigenous people about how we are using their medicine, um, or medicine that does like that comes from, that comes from Africa. Mary Carreon: Um, also with that, I know that there is a massive just devastating opioid crisis here that we need to do something about and drug crisis that we need to be helping with. And this medicine is something that can really, really, really help. Um, I find it absolutely fascinating that the right is the most interested party in moving all of this forward, like psychedelic medicine forward. Mary Carreon: And I, I currently have my popcorn and I am watching and I am eating it, and I am going to witness whatever goes down. Um, but I'm, I, I hope that, uh, things are moving in a way that is going to be beneficial for the people and also not completely leave behind the indigenous communities where this medicine comes from. Joe Moore: [01:00:00] Mm-hmm. Mary Carreon: We'll see how it goes. Yeah. We'll see how it goes. We'll see how it goes. It Joe Moore: would be lovely if we can figure it out. Um, I know, and I think, uh, Lucy Walker has a film coming out on Iboga. Mm. I got to see it at Aspen, um, symposium last summer, and it was really good. Mm. So I'm sure it'll be cut different, but it's so good and it tells that story. Joe Moore: Okay. Um, in a helpful way. I'm gonna, I, yeah. I always say I'm gonna do this. I'm like, if I have space, maybe I'll be able to email her and see if we can screen it in Colorado. But it's like a brilliant film. Yeah. Cool. This whole reciprocity conversation is interesting and challenging. And so challenging being one of the few countries that did not sign onto the Nagoya protocol. Joe Moore: Absolutely. We're not legally bound, you know, some countries are Mary Carreon: I know. Yes, yes, yes. So Joe Moore: we're, you know, how do we do that? How do we do that skillfully? We still haven't done it with, um, first Nations folks around their [01:01:00] substances. Um, I think mushrooms are a little flexible and account of them being global, um, from Africa to Ireland and beyond. Joe Moore: And, but you know, that's, we still want to give a nod to the people in Mexico for sure. Yeah, absolutely. Absolutely. Yeah. Um, yeah. Yeah, it's, I had some fun commentary there that I would love to flesh out someday. Uh, but yeah, it's not for today. Mary Carreon: Yeah, yeah, yeah. Um, there's, yeah, there's obviously, there's obviously a lot with the conversation of reciprocity here and, um, I know, I, I don't know. Mary Carreon: I, I, what I do know is that we need to be listening to the indigenous people, not just listening to them second, like secondhand or listening to them, uh, once we have moved something forward, like actually consulting with them as the process goes. And that, you know, the way that both parties move, indigenous folks and, uh, western folks move, uh, are at inherently different paces. Mary Carreon: And, [01:02:00] um, I just hope, and I wish, and I, I hope, I just hope that, uh, Western what, like the Western party, the western folks who are diving into these medicines. Slow the fuck down and listen and just are able to at least make one right move. Just one, just like you. Like it's, doesn't have to be this, it doesn't have to be that hard. Mary Carreon: Although the pace of capitalism usually propels, uh, the western folks at, at a much quicker rate than, u

In Hour 2, Andy and Randy talk about the injury to Tyreek Hill and bad QB play from the Bengals, some of the leftover weekend reactions from a busy weekend in college football, and Backpage with Beau.

Preview: The origins of the UK involve many cultural incomers, including the earlier Anglo-Saxons and Romans. The Viking "great heathen army" (c. 865), referred to in Old Englishas micel here, should be understood as smaller, mobile war bands with various leaders. This structure allowed the Norseinvaders to utilize waterways, split their forces, and maintain the element of surprise, complicating defensive predictions. Retry

#OZWATCH: JEREMY ZAKIS, NEW SOUTH WALES. #FRIENDSOFHISTORYDEBATINGSOCIETY. SUMMARY: Dallas the spoodle encountered a teenage magpie that rolled onto its back, initiating play as magpies do among themselves. Confused, Dallas sat and wagged his tail. Cockatoos are currently preoccupied stripping bark off pine trees due to the wind. Smaller birds (noisy miners, rosellas) have moved to the front garden to feed on small insects. 1963